DK145778B - ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES - Google Patents

ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES Download PDF

Info

Publication number
DK145778B
DK145778B DK436169AA DK436169A DK145778B DK 145778 B DK145778 B DK 145778B DK 436169A A DK436169A A DK 436169AA DK 436169 A DK436169 A DK 436169A DK 145778 B DK145778 B DK 145778B
Authority
DK
Denmark
Prior art keywords
acid
phenoxyphenyl
methyl
ether
compounds
Prior art date
Application number
DK436169AA
Other languages
Danish (da)
Other versions
DK145778C (en
Inventor
Winston Stanley Marshall
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US752800A external-priority patent/US3649679A/en
Priority claimed from US828756A external-priority patent/US3600437A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to DK240577A priority Critical patent/DK141439B/en
Priority to DK240477A priority patent/DK240477A/en
Priority to DK240677A priority patent/DK144760C/en
Publication of DK145778B publication Critical patent/DK145778B/en
Application granted granted Critical
Publication of DK145778C publication Critical patent/DK145778C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/295Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

(19) DANMARK(19) DENMARK

®| (12) FREMLÆGGELSESSKRIFT od 145778 Β® | (12) PUBLICATION OR 145778 Β

DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM

(21) Ansøgning nr. 4^61/69 (51) IntCI.3 C 07 C 59/68 (22) Indleveringsdag 1^·· ®dg* 19^9 C 07 C 69/736 (24) Løbedag l4.aug. 1969 C 07 C 83/10 (41) Aim. tilgængelig 16. feb. 1970 C 07 C 103/00 (44) Fremlagt 28. feb. 19¾ (86) International ansøgning nr. ~ (86) International indleveringsdag (85) Videreførelsesdag -(62) Stamansøgning nr. -(21) Application No. 4 ^ 61/69 (51) IntCI.3 C 07 C 59/68 (22) Filing Day 1 ^ ·· ®dg * 19 ^ 9 C 07 C 69/736 (24) Running Day l4aug . 1969 C 07 C 83/10 (41) Aim. available Feb 16 1970 C 07 C 103/00 (44) Submitted Feb 28 19¾ (86) International Application No. ~ (86) International Filing Day (85) Continuation Day - (62) Master Application No. -

(30) Prioritet 15· aug. 1968* 752800, US 15· aug. 1968, 752801, US 28. maj 1969* 828756, US(30) Priority 15 Aug 1968 * 752800, US Aug 15 1968, 752801, US May 28, 1969 * 828756, US

(71) Ansøger ELI LILLY AND COMPANY, Indianapolis, US.(71) Applicant ELI LILLY AND COMPANY, Indianapolis, US.

(72) Opfinder Winston Stanley Marshall, US.(72) Inventor Winston Stanley Marshall, US.

(74) Fuldmægtig Ingeniørfirmaet Hofman-Bang & Boutard.(74) Associate Engineer Hofman-Bang & Boutard.

(54) Analogifremgangsmåde til fremstil« ling af 5-phenoxyphenylalkansyre-derivater.(54) Analogous process for the preparation of 5-phenoxyphenylalkanoic acid derivatives.

Den foreliggende opfindelse angår en analogifremgangsmåde til fremstilling af hidtil ukendte 3-phenoxyphenylalkansyre-derivater med den i kravets indledning anførte almene formel I, og fremgangsmåden ifølge opfindelsen er ejendommelig ved det i kravets kendetegnende del anførte.The present invention relates to an analogous process for the preparation of novel 3-phenoxyphenylalkanoic acid derivatives of the general formula I set forth in the preamble of the claim, and the process of the invention is characterized by the characterizing part of the claim.

Mange mennesker og dyr vides at lide af forskellige rheumatiske D lidelser, der medfører betændelser, opsvulmning, ømhed, nedsat mo- ® bilitet, smerte og feber. Der findes en række tilgængelige anti- inflammatoriske midler, som har vist sig at være effektive ved ij? den symptomatiske behandling af lidelser såsom rheumatoid arthri- “ tis, rheumatoid spondylitis og ostearthritis i hoften, men disse ^ midler har et antal uønskede bivirkninger.Many people and animals are known to suffer from various rheumatic D disorders that cause inflammation, swelling, tenderness, reduced mobility, pain and fever. There are a number of available anti-inflammatory agents that have been shown to be effective in the symptomatic treatment of disorders such as rheumatoid arthritis, rheumatoid spondylitis and osteoarthritis of the hip, but these agents have a number of undesirable side effects.

3 2 1457783 2 145778

Fra USA patentskrift nr. 3 385 886 kendes et antal beslægtede forbindelser med antiinflammatorisk virkning. Der omtales udelukkende para-substituerede forbindelser, mens nærværende opfindelse omhandler meta-substituerede forbindelser.U.S. Patent No. 3,385,886 discloses a number of related compounds having anti-inflammatory effect. Only para-substituted compounds are referred to, while the present invention relates to meta-substituted compounds.

Ved sammenligning imellem et antal af de omhandlede forbindelser med usubstitueret p-phenoxyphenyleddikesyre samt med kendte para-substituerede syrer og visse ortho-substituerede syrer har det vist sig, at de omhandlede forbindelser er lige så aktive som de fra ovennævnte USA patentskrift kendte forbindelser, men bevirker en væsentligt mindre irritation af mavesækken.By comparison between a number of the compounds of the invention with unsubstituted p-phenoxyphenylacetic acid as well as with known para-substituted acids and certain ortho-substituted acids, it has been found that the compounds of this invention are as active as the compounds of the above-mentioned United States patent, but causes much less irritation to the stomach.

Den foreliggende opfindelse omhandler således en fremgangsmåde til fremstilling af hidtil ukendte forbindelser, som er udmærkede antiinflammatoriske midler, og som udover deres antiinflam-matoriske virkning udøver en mild, aspirinlignende analgetisk og antipyretisk virkning.Thus, the present invention relates to a process for the preparation of novel compounds which are excellent anti-inflammatory agents and which, in addition to their anti-inflammatory action, exert a mild, aspirin-like analgesic and antipyretic effect.

De omhandlede 3-phenoxyphenylalkansyrer og deres farmaceutisk acceptable derivater kan betegnes ved den almene formel II: *2 Γ)-0 11 hvori de anvendte symboler har den i kravets indledning angivne betydning.The disclosed 3-phenoxyphenylalkanoic acids and their pharmaceutically acceptable derivatives may be designated by the general formula II: wherein the symbols used have the meaning given in the preamble of the claim.

Forbindelserne med den almene formel I er udmærkede antiinflammatoriske midler, og mange af dem har en ED,.q på 0,9-5,0 mg/kg ved erythema-blokeringsprøven. De omhandlede forbindelser er nyttige ved behandlingen af inflammatoriske sygdomme hos pattedyr. Udover deres antiinflammatoriske virkning har forbindelserne som nævnt en mild analgetisk og antipyretisk virkning. De kan anvendes i terapeutiske blandinger, der som aktiv ingrediens inde- H5778 3 holder en eller flere af forbindelserne med formel I sammen med et farmaceutisk acceptabelt diluens eller bærestof. Forbindelserne indgives i reglen i pattedyr i doser på 0,2-50,0 mg/kg legemsvægt daglig, enten i en eller i flere doser i løbet af 24 timer. Det er underforstået, at såvel den d- som den 1-isomere af oc-alkyl-forbindelserne er omfattet af opfindelsen. Således kan f.eks. c<-alkylsyrerne spaltes i deres d- og 1-isomere ved velkendte metoder, og de to isomere har vist sig at have i det væsentlige identisk virkning. Man kan således anvende såvel den racemiske blanding som den d- og 1-isomere ved behandlingen af betændelse, smerte og feber hos pattedyr.The compounds of general formula I are excellent anti-inflammatory agents, many of which have an ED, of 0.9-5.0 mg / kg in the erythema-blocking test. The present compounds are useful in the treatment of inflammatory diseases in mammals. In addition to their anti-inflammatory effect, the compounds have a mild analgesic and antipyretic effect. They can be used in therapeutic mixtures containing as active ingredient one or more of the compounds of formula I together with a pharmaceutically acceptable diluent or carrier. The compounds are usually administered in mammals at doses of 0.2-50.0 mg / kg body weight daily, either in one or in multiple doses over 24 hours. It is to be understood that both the d- and the 1-isomer of the o-alkyl compounds are encompassed by the invention. Thus, e.g. The C 1 -alkyl acids are cleaved into their d and 1 isomers by well known methods, and the two isomers have been found to have essentially identical effect. Thus, both the racemic mixture and the d- and 1-isomer can be used in the treatment of inflammation, pain and fever in mammals.

Nogle af de omhandlede forbindelser, især sådanne, hvori og Y2 betegner hydrogen, n er 0, er hydrogen, methyl eller ethyl og Z er C00H, eller salte deraf, har overraskende nok vist sig at forhøje den analgetiske virkning af visse analgetiske midler, såsom estrene af 1,2-diphenyl-2-hydroxy-3-methyl-(substitueret 4-amino)butaner, især α-d-propoxypheu (identificeret kemisk som a-d-l,2-diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutan) samt visse narkotiske analgetiske midler såsom morfin og codein, når de indgives i forbindelse hermed. Forhøjelsen af den analgetiske virkning forekommer, når ca. 1 vægtdel af forbindelsen, der er fremstillet ved fremgangsmåden ifølge opfindelsen indgives i det væsentlige samtidig med eller fra 1 time før til 1 time efter indgivelsen af 0,005-20 vægtdele af det analgetiske middel. Generelt kan man sige, at man for at opnå en større analgetisk virkning må indgive 0,5-50 mg/kg af en af forbindelserne, der er fremstillet ved fremgangsmåden ifølge opfindelsen sammen med den sædvanlige terapeutiske dosis af det analgetiske middel.Some of the compounds of the present invention, especially those wherein and Y 2 represents hydrogen, n is 0, is hydrogen, methyl or ethyl and Z is C00H, or salts thereof, has surprisingly been found to increase the analgesic effect of certain analgesic agents such as the esters of 1,2-diphenyl-2-hydroxy-3-methyl (substituted 4-amino) butanes, in particular α-d-propoxypheu (chemically identified as adl, 2-diphenyl-2-propionoxy-3-methyl-4- dimethylaminobutane) as well as certain narcotic analgesics such as morphine and codeine when administered therewith. The increase in the analgesic effect occurs when approx. 1 part by weight of the compound prepared by the method of the invention is administered substantially simultaneously with or from 1 hour before to 1 hour after the administration of 0.005-20 parts by weight of the analgesic agent. In general, it can be said that to obtain a greater analgesic effect, one must administer 0.5-50 mg / kg of one of the compounds prepared by the method of the invention together with the usual therapeutic dose of the analgesic agent.

De omhandlede forbindelser fremstilles ved i sig selv kendte fremgangsmåder til fremstilling af phenyleddikesyrer, phenylpropionsyrer og derivater deraf, hvilke fremgangsmåder 1 3 er illustreret nedenfor. I det følgende har R -R den samme betydning som i kravets indledning og "Ar" betegner den i formel I angivne gruppe: 4 145778The present compounds are prepared by methods known per se for the preparation of phenylacetic acids, phenylpropionic acids and derivatives thereof, the methods of which are illustrated below. In the following, R-R has the same meaning as in the preamble of claim and "Ar" denotes the group set forth in Formula I: 4 145778

Yo ___ Α. SyrerYo ___ Α. Acids

I* År-GH:3 Ar-GH2-Br FaCFj Ar-CH2-0F H20 År-CH2-C00HI * Year-GH: 3 Ar-GH2-Br FaCFj Ar-CH2-0F H20 Year-CH2-C00H

Methylgruppen i en passende methyldiarylether halogeneres ved omsætning med N-bromsuccinimid (NBS), N-chlorsuccin-imid, sulforylchlorid eller et lignende halogeneringsmiddel, ved anvendelse af en passende katalysator, såsom benzoyl-peroxid eller azo-bis-iso-butyronitril i et inert opløsningsmiddel såsom carbontetrachlorid eller et andet halogeneret carbonhydrid. Den resulterende halogenmethyldiarylether omsættes med natrium- eller kaliumcyanid, fortrinsvis i en di-methylsulfoxidopløsning. Den således opnåede nitril hydrolyseres til den korresponderende carboxylsyre ved behandling med enten sure eller basiske reagenser på kendt måde.The methyl group in a suitable methyl diaryl ether is halogenated by reaction with N-bromosuccinimide (NBS), N-chlorosuccinimide, sulforyl chloride or a similar halogenating agent, using a suitable catalyst such as benzoyl peroxide or azo-bis-isobutyronitrile in an inert solvent such as carbon tetrachloride or another halogenated hydrocarbon. The resulting halomethyl diaryl ether is reacted with sodium or potassium cyanide, preferably in a dimethyl sulfoxide solution. The nitrile thus obtained is hydrolyzed to the corresponding carboxylic acid by treatment with either acidic or basic reagents in known manner.

14577 8 5 Η Η Η η Η Η Ο σ' ju .14577 8 5 Η Η Η η Η Η Ο σ 'ju.

• · · !> 4 3» > I ^ 4• · ·!> 4 3 »> I ^ 4

Ο I IΟ I I

ο Gο G

Γύ {g tcj ι γ\Γ roΓύ {g tcj ι γ \ Γ ro

Ο I IΟ I I

o o o o o a ro° g 2 P? : — al H* i "p i- a i*; ri? a w x Kf ro \ p> a ro \ ^ οι a a o S lo ^ w Ίo o o o o a ro ° g 2 P? : - all H * i "p i- a i *; ri? A w x Kf ro \ p> a ro \ ^ οι a a o S lo ^ w Ί

o * Wo * W

o v a> >o v a>>

^ B^ B

S» · ι I IS »· ι I I

*3 a-o a - o ®* 3 a-o a - o ®

g- i i- k i- w Cg- i i- k i- w C

4 Oli 2 _ i a o o < a-o o a £ r- a o o 2 0 8 w g4 Oli 2 _ i a o o <a-o o a £ r- a o o 2 0 8 w g

• § n? S• § n? S

« v£ J,° ro > ►s a-o r>v . w o i- a D> W o ro a o ji o > ^ a > . S» 4 ^4 1 t a-o a-o«V £ J, ° ro> ►s a-o r> v. w o i- a D> W o ro a o ji o> ^ a>. S »4 ^ 4 1 t a-o a-o

H «—* HH «- * H

O OISLAND ISLAND

8^ § & ° ro° M -v£ ro 6 U5778 HH Η <3 Η Η • Η Οι • · 4 4 > I I 48 ^ § & ° ro ° M -v £ ro 6 U5778 HH Η <3 Η Η • Η Οι • · 4 4> I I 4

ο =ο Ο Iο = ο Ο I

i I? θ a ι μi i? θ and ι μ

OJ · Ο IOJ · Ο I

Μ Ο 2? * 5 ύ “ 1- 4=· ί» Ο Ο V Μ Ο Γΰ > ιί5 Μ>Ο Ο 2? * 5 ύ “1- 4 = · ί» Ο Ο V Μ Ο Γΰ> ιί5 Μ>

? νϋ° S? νϋ ° S

Ο -Ο ΓΟ a a _ ο ι > ο Ο ^ \f 00W ο =ό > a ι 4Ο -Ο ΓΟ a a _ ο ι> ο Ο ^ \ f 00W ο = ό> a ι 4

Ο Ο IΟ Ο I

3 « « S3 «« S

8 /w\8 / w \

bO O ObO O O

\ r ^ a o\ r ^ a o

0 O0 O

> O Q> O Q

4o ro g*·£ ^ V t> Μ I SI ff uT 0=0 H o 2- o o r£ tf & p o =o a a 0 I VJi a ^ Ψ ? ^ Ά > “ > nT 4 >- 4 \ | *" 1 a o-» < 0-0 Q> / \ H J-* 00 I ^ O O - < O > a o 2 a ^ o ® 1 o ^ o-o ro li? tf F ^5 o o ° * * μ <+4o ro g * · £ ^ V t> Μ I SI ff uT 0 = 0 H o 2- o o r £ tf & p o = o a a 0 I VJi a ^ Ψ? ^ Ά> “> nT 4> - 4 \ | * "1 a o-» <0-0 Q> / \ H J- * 00 I ^ OO - <O> ao 2 a ^ o ® 1 o ^ oo ro li? Tf F ^ 5 oo ° * * µ < +

> ΓΟ CD> ΓΟ CD

4 o m o-i ^ ^ - U? P 1° s«_& o a 1 m_1 o · > a - o a-o M 7 - « - / \ 0-0 0.0 o4 o m o-i ^^ - U? P 1 ° s «_ & o a 1 m_1 o ·> a - o a-o M 7 -« - / \ 0-0 0.0 o

MM O O OMM O O O

bo i O O Olive in O O O

o a a μ o o a 7 145778 e: c hH t-> c cr m · > > > 3o a a μ o o a 7 145778 e: c hH t-> c cr m ·>>> 3

4 . 3 I4. 3 I

a - ά a -o Jl.a - ά a -o Jl.

>— II »—ti O> - II »—ti O.

° ° . tf *^1 — a o5^ o o a ro a i a w· 3 — ,o o o et a a ^ a 11 i\j W ro >.° °. tf * ^ 1 - a o5 ^ o o a ro a i a w · 3 -, o o o et a a ^ a 11 i \ j W ro>.

ώ ^ a ns S3' o a i i o hT 8 tD O ,ώ ^ a ns S3 'o a i i o hT 8 tD O,

3 ΛΡ iX3 ΛΡ iX

v /> a 3v /> a 3

^ \J1 I^ \ J1 I

V, Ω V ? a -o > ^V, Ω V? a -o> ^

H il 3 OH il 3 O

a a - ό ι\? I H II -~-a a - ό ι \? I H II - ~ -

—> O EJ-> O EJ

0 a o0 a o

tf ά / Stf ά / S

»W o M»W o M

I O L J BI O L J B

h to Xf . , Ih to Xf. , I

1 a 05 0 VJ1 *ss| * 1 a * tf ' tf \tf l· > > i° -1 a 05 0 VJ1 * ss | * 1 a * tf 'tf \ tf l ·>> i ° -

ct rt ^ CPct rt ^ CP

3> 3» tj ^ hi hi I ->> ^ I _ I O o a -o a -o a n t-a na to ^ 1 i 10) *—S O •'—-N 0) 0 a O rt ni°3> 3 »tj ^ hi hi I - >> ^ I _ I O o a -o a -o a n t-a na to ^ 1 i 10) * —S O • '—- N 0) 0 a O rt ni °

*— O* - Oh

3 O 3 1 O o3 O 3 1 O o

0 Ω O0 Ω O

a ro . o \tf ^ * \tf 3 ψ a -ό > na 3 1 V* 1 — a - o 0 na tf v a 3 ΙΟand ro. o \ tf ^ * \ tf 3 ψ a -ό> to 3 1 V * 1 - a - o 0 to tf v a 3 ΙΟ

1 I1 I

o o o o O o a a 8 14577«o o o o O o a a 8 14577 «

Den ifølge reaktionsskema I fremstillede nitril kan som vist ovenfor alkyler es med et alif atisk halogenid eller tosylat (R-jXg) i flydende ammoniak i nærværelse af natriumamid under dannelse af en a-alifatisk substitueret nitril. Den alkylerede uitril hydro-lyseres under dannelse af den korresponderende carboxylsyre (reaktionssekvens Ila). På lignende måde kan man alkylere en aryleddikesyre i ot-stillingen i forhold til carboxylgruppen, >- som vist i reaktionssekvens Ilb.The nitrile prepared according to Scheme I, as shown above, can be alkylated with an aliphatic halide or tosylate (R-xXg) in liquid ammonia in the presence of sodium amide to form an α-aliphatic substituted nitrile. The alkylated utryl is hydrolyzed to give the corresponding carboxylic acid (reaction sequence IIa). Similarly, one can alkylate an arylic acetic acid at the ot position with respect to the carboxyl group, - as shown in reaction sequence IIb.

Ted en anden fremgangsmåde, som vist i nc og Ild kan man konvertere en arylacetatester, såsom ethylesteren, eller en arylaceto-nitril til den korresponderende malonester eller cyanoeddikesyre-ester ved indvirkning af metallisk natrium og diethylcarbonat. Ethvert af disse derivater kan derpå alkyleres. En sådan alkylering udføres i reglen ved at omsætte malonesteren eller cyanoeddike-syreesteren med stærk base, såsom natriumethoxid, natriummethoxid, kalium-tert-butoxid eller natriumhydrid, hvorved der dannes en carbanion ved α-carbonatornet. En påfølgende behandling af carb-anion-mellemproduktet med et alkyleringsmiddel, såsom et alkyl-halogenid eller -tosylat (¾¾) giver det korresponderende a-alkylmalonester- eller cyanoeddikesyreesterderivat. Hvert af disse kan hydrolyseres til en korresponderende ος-alkylarylmalonsyre, som derpå decarboxyleres på kendt måde, hvorved man får den ønskede ot-alkylaryleddikesyre.By another method, as shown in nc and Ild, an aryl acetate ester such as the ethyl ester or an aryl acetonitrile can be converted to the corresponding malone ester or cyanoacetic acid ester by the action of metallic sodium and diethyl carbonate. Any of these derivatives can then be alkylated. Such alkylation is usually carried out by reacting the malone ester or cyanoacetic acid ester with a strong base such as sodium ethoxide, sodium methoxide, potassium tert-butoxide or sodium hydride, thereby forming a carbanion at the α-carbonator network. A subsequent treatment of the carb anion intermediate with an alkylating agent such as an alkyl halide or tosylate (¾¾) gives the corresponding α-alkylmalon ester or cyanoacetic acid ester derivative. Each of these can be hydrolyzed to a corresponding ος-alkylaryl malonic acid, which is then decarboxylated in known manner to give the desired o-alkylaryl acetic acid.

En nitril, der er fremstillet ifølge reaktionssekvens I, kan om ønsket methyleres på følgende måde (III): Nitrilen kondenseres med ethylformiat i basisk medium, f.eks. i nærværelse af natrium-hydrid eller natriummethoxid i et inert earbonhydridopløsnings-middel, såsom benzen. Det resulterende hydroxymethylenderivat benzoyleres ved indvirkning af enten bensoesyreauhydrid eller benzoylchlorid og pyridin og benzoesyreesteren hydogeneres derpå i nærværelse af en ædelmetalkatalysator under dannelse·· af den ønskede a-methylarylaeetonitril, som derpå hydrolyseres som oven for.A nitrile prepared according to reaction sequence I can, if desired, be methylated as follows (III): The nitrile is condensed with ethyl formate in basic medium, e.g. in the presence of sodium hydride or sodium methoxide in an inert hydrocarbon solvent such as benzene. The resulting hydroxymethylene derivative is benzoylated by the action of either benzoic acid anhydride or benzoyl chloride and pyridine and the benzoic acid ester are then hydrogenated in the presence of a noble metal catalyst to form the desired α-methyl arylaeetonitrile, which is then hydrolyzed as above.

Eventuelt kan den ønskede α-methylarylacetonitril fremstilles ved følgende reaktionsserier (IV): Aryloxyacetophenon 9 145778 (fremstillet ved en Ullman-ethersyntese) reduceres enten med hydrogen i nærværelse af en ædelmetalkatalysator eller med et metal-hydrid, såsom lithiumaluminiumhydrid, lithium- eller uatriumbor-hydrid, til den korresponderende carbinol. Omdannelse af denne carbinol til det korresponderende bromid kan udføres ved behandling af carbénolen med phosphortribromid, fortrinsvis i et inert opløsningsmiddel såsom chloroform, benzen eller carbontetrachlorid. Det således opnåede bromid omsættes med natriumcyanid, fortrinsvis i en dimethylsulfoxidopløsning under dannelse af en nitril, som derpå hydrolyseres som ovenfor til den ønskede carboxylsyre.Optionally, the desired α-methylarylacetonitrile may be prepared by the following reaction series (IV): Aryloxyacetophenone 9 145778 (prepared by a Ullman ether synthesis) is reduced either by hydrogen in the presence of a noble metal catalyst or by a metal hydride such as lithium aluminum hydride, lithium boron or uranium boron. hydride, to the corresponding carbinol. Conversion of this carbinol to the corresponding bromide can be accomplished by treating the carbenol with phosphorus tribromide, preferably in an inert solvent such as chloroform, benzene or carbon tetrachloride. The bromide thus obtained is reacted with sodium cyanide, preferably in a dimethyl sulfoxide solution to form a nitrile, which is then hydrolyzed as above to the desired carboxylic acid.

De således opnåede α-alkylsyrer kan spaltes i deres d- og 1-isomere på kendt måde.The α-alkyl acids thus obtained can be cleaved into their d- and 1-isomers in known manner.

De ønskede phenoxyphenylalkansyrer kan også fremstilles ved Willgerodt reaktionen (V).. Ved denne reaktion ophedes en passende -phenoxyphenylalkylketon med morpholin og svovl, og det resulterende thioamid hydrolyseres under dannelse af det ønskede alkansyrederivat, som kan alkyleres ved behandling med to ækvivalenter natriumamid i flydende ammoniak, efterfulgt af en tilsætning af alkylhalogenid eller -tosylat (11^X2) som illustreret i Ilb.The desired phenoxyphenylalkanoic acids can also be prepared by the Willgerodt reaction (V). In this reaction, a suitable -phenoxyphenylalkyl ketone is heated with morpholine and sulfur and the resulting thioamide is hydrolyzed to form the desired alkanoic acid derivative which can be alkylated by treatment with two equivalents of sodium amide in liquid ammonia, followed by the addition of alkyl halide or tosylate (11 x X 2) as illustrated in Ilb.

Syrerne fremstillet ifølge opfindelsen, hvori n er forskellig fra 0, kan fremstilles på kendt måde ved Wittig-reaktionen som vist i reaktionsskema Via og VIb. De umættede estere (som i Via) eller nitriler (som i VIb), der opstår som mellemprodukter, kan hydrogeneres i nærværelse af en ædelmetalkatalysator, såsom platin, og de resulterende mættede estere og nitriler kan hydrolyseres, som vist ovenfor, til de ønskede carboxylsyrer.The acids prepared according to the invention, wherein n is different from 0, can be prepared in known manner by the Wittig reaction as shown in Schemes Via and VIb. The unsaturated esters (as in Via) or nitriles (as in VIb) arising as intermediates can be hydrogenated in the presence of a precious metal catalyst such as platinum, and the resulting saturated esters and nitriles can be hydrolyzed, as shown above, to the desired carboxylic acids .

10 U577« C. Estere, 7IIIa. Ar-CH-(GH,) COOH lUOH/HCl Ar-CH-(CHJgOOR, ~L -* S110 U577 «C. Estere, 7IIIa. Ar-CH- (GH,) COOH IUOH / HCl Ar-CH- (CHJgOOR, ~ L - * S1

Vlllb. Ar-CE- (CH,) COOH SOGI, Ar-CH-(CH,)C0G1- I ^ C \ I ^ U- R1 R1 s2ohVIIIb. Ar-CE- (CH,) COOH SOGI, Ar-CH- (CH,) COG1- I ^ C \ I ^ U- R1 R1 s2oh

VV

Ar-CH-(CH2)uC00R2Ar-CH- (CH 2) uC00R2

AA

Garboxylsyrerne, der er fremstillet ved fremgangsmåden beskrevet ovenfor, kan omdannes til de korresponderende estere på kendt måde, såsom ved at opvarme syren med en alkohol i nærværelse af en mineralsyre (Villa) eller ved at omdanne syren til det korresponderende syreehlorid, og derefter at omsætte dette med en alkohol, fortrinsvis i nærværelse af en forbindelse, der kan optage HGl (VIHb).The garboxylic acids prepared by the process described above can be converted to the corresponding esters in known manner, such as by heating the acid with an alcohol in the presence of a mineral acid (Villa) or by converting the acid to the corresponding acid chloride, and then reacting this with an alcohol, preferably in the presence of a compound which can take up HG1 (VIHb).

D. Amider.D. Amider.

IX. Ατ-0Η-(0Η2)η-ς^ (Sj)2KH Ar-CH-(CH^-C!^ RIX. Ατ-0Η- (0Η2) η-ς ^ (Sj) 2KH Ar-CH- (CH

Ri Xl S ?Ri Xl S?

Amiderne fremstilles ved omsætning af det ovennævnte syre-chlorid med en amin. Reaktionen udføres sædvanligvis i et inert opløsningsmiddel, såsom chloroform, benzen eller carbontetrachlorid, i nærværelse af et stof, der kan binde syren, såsom pyridin eller ^CO^, eller i et opløsningsmiddel af en tertiær amin, såsom collidin, lutidin eller triethylamin.The amides are prepared by reacting the above acid chloride with an amine. The reaction is usually carried out in an inert solvent such as chloroform, benzene or carbon tetrachloride, in the presence of a substance capable of binding the acid such as pyridine or C

Udgangsmaterialerne for de foregående reaktioner fremstilles let ved en Ullman-diarylethersyntese, som beskrevet af Bacon og Stevard, J. Am. Chem. Soc., 8£, 4953 (1965) og angivet ved følgende reaktion:The starting materials for the foregoing reactions are readily prepared by a Ullman diaryl ether synthesis, as described by Bacon and Stevard, J. Am. Chem. Soc., £ 8, 4953 (1965) and indicated by the following reaction:

Ar*-OH + Ar»X.—----^ Ar * -O-År« hvori Ar’ betegner en usubstitueret phenylgruppe og År” betegner den substituerede phenylgruppeAr * -OH + Ar »X. ------ ^ Ar * -O-Year« wherein Ar 'represents an unsubstituted phenyl group and Year' represents the substituted phenyl group

11 14S77S11 14S77S

T1 *2 a fra den almene formel I·T1 * 2a from the general formula I ·

Typiske mellemprodukter, som fremstilles ved den ovennævnte reaktion er følgende: 3- Phenoxyacetophenon, k.p., 117-126° C/0,08 mm; njp = 1,5865, 4- Chlor-5-methyldiphenylether, k.p., 105-113° C/0,06 mm; n^4’5 = 1,5850, 2-JChlor-5-methyldipheny lether, k.p., 120-123° C/0,08 mm; n£5»5 = 1,5850, 4-Pluor-5-methyldip]ienyletter, k.p., 75-85° C/0,05 mm; n^4 = 1,5565, 4-Methyl-5-phenoxyaeetophenon, k.p., 120-132° C/0,05 mm; ζξ5 = 1,5888, 2-Methoxy-5-phenoxyaeetophenon, k.p., 132-140° C/0,15 mm; n£5 = 1,5864.Typical intermediates prepared by the above reaction are the following: 3- Phenoxyacetophenone, b.p., 117-126 ° C / 0.08 mm; njp = 1.5865, 4- Chloro-5-methyl diphenyl ether, b.p., 105-113 ° C / 0.06 mm; n = 4'5 = 1.5850, 2-J-Chloro-5-methyl diphenyl ether, b.p., 120-123 ° C / 0.08 mm; n? 5 »5 = 1.5850, 4-Fluoro-5-methyl dip] enyl ether, b.p., 75-85 ° C / 0.05 mm; n ^ 4 = 1.5565, 4-Methyl-5-phenoxyyaetophenone, b.p., 120-132 ° C / 0.05 mm; ζξ5 = 1.5888, 2-Methoxy-5-phenoxyyaetophenone, b.p., 132-140 ° C / 0.15 mm; n £ 5 = 1.5864.

Opfindelsen illustreres nærmere véd de nedenstående eksempler. EKSEMPEL 1The invention is further illustrated by the following examples. EXAMPLE 1

Fremstilling af 3-nhenoxvphenvl-eddikesvrePreparation of 3-Nhenoxyphenyl Acetic Acid

Til 26 ml morpholin sattes 42,4 g m-phenoxyacet ophenon og 9»6 g svovl. Reaktionsblandingen opvarmedes under tilbage svaling og omrøring i 20 timer. Til reaktionsblandingen sattes derpå 700 ml 15 f> vandig kaliumhydroxid og en ringe mængde ethylalkohol. Reaktionsblandingen kogtes -under tilbagesvaling og omrøring i yderligere 20 timer. Der afdestillerede ca. 200 ml af opløsningsmidlet. Den tilbageværende reaktionsblanding filtreredes varmt, afkøledes delvis med is og gjordes sur med koncentreret saltsyre, hvorved der udfældedes et olieagtigt bundfald, som derpå krystalliserede. Det krystallinske bundfald filtreredes fra, udvaskedes adskillige gange med vand og tørredes, hvorved man fik 45,9 g urent produkt i form af et gulorange fast stof. Det urene produkt suspenderedes i kogende hexan, og der tilsattes ethylacetat, indtil produktet var 12 145778 opløst. Opløsningen behandledes med aktivt kul, filtreredes og afkøledes under dannelse af 22,7 g af hvide flager af 3-phenoxyphe-nyleddikesyre, smp. 84 - 86 °C, pK'a = 6,9.To 26 ml of morpholine were added 42.4 g of m-phenoxyacet ophenone and 9 »6 g of sulfur. The reaction mixture was heated under reflux and stirred for 20 hours. To the reaction mixture was then added 700 ml of 15 µl of aqueous potassium hydroxide and a small amount of ethyl alcohol. The reaction mixture was refluxed and stirred for a further 20 hours. There distilled approx. 200 ml of the solvent. The residual reaction mixture was filtered hot, partially cooled with ice and acidified with concentrated hydrochloric acid to precipitate an oily precipitate which then crystallized. The crystalline precipitate was filtered off, washed several times with water and dried to give 45.9 g of crude product as a yellow-orange solid. The crude product was suspended in boiling hexane and ethyl acetate was added until the product was dissolved. The solution was treated with activated charcoal, filtered and cooled to give 22.7 g of white flakes of 3-phenoxyphenylacetic acid, m.p. 84 - 86 ° C, pK'a = 6.9.

Analyse beregnet for ci4Hi2^3: C/ ^3,66; H, 5,30,Calcd. For C 14 H 2 O 3: C, 3.66; H, 5.30,

Fundet: C, 73,85; H, 5,35.Found: C, 73.85; H, 5.35.

EKSEMPEL 2-6EXAMPLES 2-6

De følgende forbindelser fremstilledes efter fremgangsmåden ifølge eksempel 1. Ud fra passende korresponderende phenoxyacetophenon under anvendelse af passende mængder svovl og morpholin.The following compounds were prepared according to the procedure of Example 1. From suitably corresponding phenoxyacetophenone using appropriate amounts of sulfur and morpholine.

(4-Methyl-3-phenoxy)phenyleddikesyre, smp. 49-51° C, pK'a = 7,0 fra 4-meth.yl-3-pb-enoxyacetoph.enon.(4-Methyl-3-phenoxy) phenylacetic acid, m.p. 49-51 ° C, pK'a = 7.0 from 4-methyl-3-pb-enoxyacetophenone.

Analyse beregnet for Ο-^Η-^Ο^: 0, 74,36; H, 5,83;Analysis calculated for Ο- ^ Η- ^ Ο ^: 0.74.36; H, 5.83;

Pundet: C, 74,45; H, 5,88.Pound: C, 74.45; H, 5.88.

(4-Methoxy-3-p!ienoxy)phenyleddikesyre, smp. 85-87,5° C, pK’a =6,9 fra 4-methoxy-3-phenoxyacetophenon.(4-Methoxy-3-pyreneoxy) phenylacetic acid, m.p. 85-87.5 ° C, pK'a = 6.9 from 4-methoxy-3-phenoxyacetophenone.

Analyse beregnet for O^H-j^O^: C, 69,75; H, 5,46;For C ^ forH-jO O: C, 69.75; H, 5.46;

Pundet: 0, 69,47; H, 5,30.Pound: 0, 69.47; H, 5.30.

(2-Methoxy-5-phenoxy)phenyleddikesyre, smp. 90-94° C, pK'a = 7,4 fra 2 -me thoxy5 -phenoxya ce tophenon.(2-Methoxy-5-phenoxy) phenylacetic acid, m.p. 90-94 ° C, pK'a = 7.4 from 2-me thoxy5-phenoxya ce tophenone.

Analyse beregnet for O^H-^O^: c> ^9,75; H, 5,46,Analysis calculated for O 2 H- O O: c> 9.75; H, 5.46,

Pundet: 0, 69,58; H, 5,61· (2-Methyl-5-phenoxy)phenyleddikesyre, k.p., 153-163° C/0,16 mm; pK'a = 6,9 fra 2-methy1-5-phenoxyacetophenon.Pound: 0, 69.58; H, 5.61 · (2-Methyl-5-phenoxy) phenylacetic acid, b.p., 153-163 ° C / 0.16 mm; pK'a = 6.9 from 2-methyl-5-phenoxyacetophenone.

Analyse beregnet for Ο^Ξ^Ο^: 74,36; H, 5,83,Analysis calculated for Ο ^ Ξ ^ Ο ^: 74.36; H, 5.83,

Pundet: C, 72,08; H, 5,0^· EKSEMPEL 7 13Pound: C, 72.08; H, 5.0 + EXAMPLE 7 13

U577BU577B

(4- chi or~ 3-phenoxy)phenyleddike syre(4- chi or ~ 3-phenoxy) phenylacetic acid

Til 1200 ml carbontetrachlorid sattes 232,7 g 3-phenoxy-4-chlor-toluen, 196 g E-bromsuccinimid og 1,0 g benzoylperoxid. Reaktions-blandingen omrørtes og opvarmedes under tilbagesvaling i 24 timer, hvorefter den filtreredes og det faste stof udvaskedes med carbontetrachlorid. Eiltratet inddampedes til en olie og destilleredes, hvorved man fik fraktionerne A, B og C af urent 4-chlor-3-phe-noxybenz-yl bromid:, n n25 ffraktion K.P. °0 (mm)_· Ysegt (g)_ _ A 140-150 (0,08) 118,5 1,5960 B 145-153 (0,07) 190,6 1,6152 G 145-160 (0,07) 79,4 1,6250 ffraktionerne B og C kombineredes og analyseredes.To 1200 ml of carbon tetrachloride were added 232.7 g of 3-phenoxy-4-chloro-toluene, 196 g of E-bromosuccinimide and 1.0 g of benzoyl peroxide. The reaction mixture was stirred and heated under reflux for 24 hours, then filtered and the solid washed with carbon tetrachloride. The filtrate was evaporated to an oil and distilled to give fractions A, B and C of crude 4-chloro-3-pheo-benxy-benzyl bromide: n n25 fraction K.P. ° 0 (mm) _ Frosty (g) _ A 140-150 (0.08) 118.5 1.5960 B 145-153 (0.07) 190.6 1.6152 G 145-160 (0, 07) 79.4 1.6250 The fractions B and C were combined and analyzed.

Analyse beregnet for C-^H^øBrClO: C, 52,46; Ξ, 3,38; ffundet: 0, 52,25; H, 3,44.Analysis calculated for C C CH ^ øBrClO: C, 52.46; Ξ, 3.38; found: 0, 52.25; H, 3.44.

De kombinerede fraktioner B og C redestilleredes gennem en Tigreux-kolonne, hvorved man fik fraktionerne A, B, C, D og E.The combined fractions B and C were redistilled through a Tigreux column to give fractions A, B, C, D and E.

n?5 ffraktion K.P. °C (mm) Tægt (g) O_ A 105-145 (0,09) 24,2 1,5951 B 145-155 (0,09) 29,6 1,6114 0 130-136 (0,07) 79,4 1,6228 D 128-135 (0,07) 52,9 1,6218 E . 136-149 (0,06) 29,8 1,6274 MR-studier indicerede, at fraktionerne C og D indeholdt henholdsvis 91 og 92 % 4-chlor-3-phenoxybenzylbromid.n? 5 fraction K.P. ° C (mm) Cover (g) O_ A 105-145 (0.09) 24.2 1.5951 B 145-155 (0.09) 29.6 1.6114 0 130-136 (0.07) 79 , 4 1.6228 D 128-135 (0.07) 52.9 1.6218 E. 136-149 (0.06) 29.8 1.6274 MR studies indicated that fractions C and D contained 91 and 92% of 4-chloro-3-phenoxybenzyl bromide, respectively.

I ca. 400 ml dimethylsulfoxid opløstes 22,2 g 955% natriumcyanid, og reaktionsblandingen opvarmedes til ca. 50° C. Det urene 4-chlor- 3-phenoxybenzylbromid (125 g) tilsattes dråbevis under omrøring. Temperaturen holdtes ved 50-60° 0 under bromidtilsætningen. Der dannedes en rød farve straks efter tilsætningen af bromidet. Efter tilsætningen opvarmedes reaktionsblandingen til 60° C og omrørtes i 3 timer. Blandingen henstod til afkøling til stuetemperatur og 14 145778 omrørtes natten over, hvorefter den udhældtes over is og ekstra-heredes med ethylether og derpå med hexan. Ekstrakterne udvaskedes med vand og tørredes over natriumsulfat. Opløsningsmidlerne af-dampedes, hvorved der dannedes en rødlig-brun viskos olie, som destilleredes, hvorved man fik fraktionerne A, B og C af (4-ehlor-3-phenoxyphenyl)acetonitril.For approx. 400 ml of dimethyl sulfoxide were dissolved in 22.2 g of 955% sodium cyanide and the reaction mixture was heated to ca. 50 ° C. The crude 4-chloro-3-phenoxybenzyl bromide (125 g) was added dropwise with stirring. The temperature was maintained at 50-60 ° 0 during the bromide addition. A red color formed immediately after the addition of the bromide. After the addition, the reaction mixture was heated to 60 ° C and stirred for 3 hours. The mixture was allowed to cool to room temperature and stirred overnight, then poured over ice and extracted with ethyl ether and then with hexane. The extracts were washed with water and dried over sodium sulfate. The solvents were evaporated to give a reddish-brown viscous oil, which was distilled to give fractions A, B and C of (4-ehloro-3-phenoxyphenyl) acetonitrile.

2525

Eraktion K.P. °C (mm)_ Vægt (g)_ ^D_ A 170(0,4)-170(0,15) 51,6 1,5916 B 163-174 (0,08) 16,3 1,5917 0 174-190 (0,10) 2,2 1,5917Eraktion K.P. ° C (mm) _ Weight (g) _ ^ D_ A 170 (0.4) -170 (0.15) 51.6 1.5916 B 163-174 (0.08) 16.3 1.5917 0 174 -190 (0.10) 2.2 1.5917

Analyse beregnet for C^H-^qCIM) : C, 68,99; Η, 4,13r N, 5i74;Analysis calculated for C ^ HH- qCIM): C, 68.99; Η, 4.13r N, 5i74;

Eundet: 0» 68,72; Ξ, 4,20; R, 5,50.Found: 0 »68.72; Ξ, 4.20; R, 5.50.

Svir hydrolyse af nitrilen gav den korresponderende (4-chlor-3-phenoxy)phenyleddikesyre. Til 500 ml koncentreret saltsyre sattes 50,9 g af den ovennævnte nitril. Reaktionsblandingen omrørtes og opvarmedes til 85° C i 24 timer. Der tilsattes 500 ml destilleret vand til reaktionsblandingen, som derpå opvarmedes under omrøring og svag tilbagesvaling til 105° C i 4 timer. Reaktionsblandingen udhældtes i et stort rumfang isvand. Der ekstraheredes 2 gange med ethylether. De kombinerede etherfaser udvaskedes med vand og ekstraheredes med fortyndet natriumcarbonat. Ekstrakten udvaskedes derpå med ethylether og gjordes sur ved dråbevis tilsætning af 6H saltsyre under omrøring. Det dannede voluminøse hvide bundfald filtreredes og udvaskedes med vand og tørredes i vacuum, hvorved man fik 34,2 g hvidt krystallinsk (4-chlor-3-phensxy)phenyl-eddikesyre, smp. 77-80° C.Purified hydrolysis of the nitrile gave the corresponding (4-chloro-3-phenoxy) phenylacetic acid. To 500 ml of concentrated hydrochloric acid was added 50.9 g of the above nitrile. The reaction mixture was stirred and heated to 85 ° C for 24 hours. 500 ml of distilled water was added to the reaction mixture, which was then heated with stirring and refluxed to 105 ° C for 4 hours. The reaction mixture was poured into a large volume of ice water. Extract twice with ethyl ether. The combined ether phases were washed with water and extracted with dilute sodium carbonate. The extract was then washed with ethyl ether and acidified by dropwise addition of 6H hydrochloric acid with stirring. The volatile white precipitate formed was filtered and washed with water and dried in vacuo to give 34.2 g of white crystalline (4-chloro-3-phenoxy) phenylacetic acid, m.p. 77-80 ° C.

EKSEMPEL 8-9 Følgende forbindelser fremstilledes efter fremgangsmåden ifølge eksempel 7 ud fra de korresponderende toluener under anvendelse af passende mængder N-bromsuccinimid, benzoylperoxid og natriumcyanid.EXAMPLES 8-9 The following compounds were prepared according to the procedure of Example 7 from the corresponding toluene using appropriate amounts of N-bromosuccinimide, benzoyl peroxide and sodium cyanide.

(2-Chlor-5-phenoxy)phenyleddikesyre, smp. 88τ90° C, pK’a = 6,8.(2-Chloro-5-phenoxy) phenylacetic acid, m.p. 88τ90 ° C, pK'a = 6.8.

Analyse beregnet for C-^H-^ClOj: 0, 64,00; H, 4,22; ^Lået: 0, 63,73; H, 4,32.Analysis calculated for C- HH- ^ ClO₂: 0.64.00; H, 4.22; ^ Low: 0, 63.73; H, 4.32.

15 145778 (2-Fluor-5-phenoxy)phenyleddikesyre, snip. 80-82° C, pK*a = 6,65.145778 (2-Fluoro-5-phenoxy) phenylacetic acid, snip. 80-82 ° C, pK + α = 6.65.

Analyse beregnet for : C, 68,28; H, 4>50;Analysis calculated for: C, 68.28; H, 4> 50;

Fundet: C, 68,08 H, 4,43.Found: C, 68.08 H, 4.43.

EKSEMPEL 10EXAMPLE 10

Fremstilling af 2-(3-phenoxyphenyl)propionsyre A. 5-Phenoxyaceto-phenon. En blanding bestående af 908 g (6,68 mol) m-hydroxyacetophenon, 4500 g (28,6 mol) brombenzen, 996 g (7,2 mol) vandfri kaliumearbonat ©g 300 g kobberbronze opvarmedes under tilbagesvaling indtil vanddannelsen var fuldstændig, under anvendelse af en Dean-Stark vandudskiller. Blandingen om-rørtes og opvarmedes under tilbagesvaling i 24 timer. Efter afkøling til stuetemperatur fortyndedes reaktionsblandingen med et lige så stort rumfang chloroform og filtreredes. Filtratet udvaskedes med 5 % saltsyre og derpå med 5 % natriumhydroxid og vand, tørredes over natriumsulfat og inddampedes i vacuum. Den olieagtige remanens destilleredes gennem en 15 cm Tigreux-kolonne, hvorved man fik 918 g 3-phenoxyacetophenon, k.p. 120-121° C (0,09 mm), ηψ =» 1,5868.Preparation of 2- (3-phenoxyphenyl) propionic acid A. 5-Phenoxyaceto-phenone. A mixture consisting of 908 g (6.68 mole) of m-hydroxyacetophenone, 4500 g (28.6 mole) of bromobenzene, 996 g (7.2 mole) of anhydrous potassium carbonate © g 300 g of copper bronze was heated at reflux until the formation of water was complete, below use of a Dean-Stark water separator. The mixture was stirred and heated under reflux for 24 hours. After cooling to room temperature, the reaction mixture was diluted with an equal volume of chloroform and filtered. The filtrate was washed with 5% hydrochloric acid and then with 5% sodium hydroxide and water, dried over sodium sulfate and evaporated in vacuo. The oily residue was distilled through a 15 cm Tigreux column to give 918 g of 3-phenoxyacetophenone, m.p. 120-121 ° C (0.09 mm), ηψ = »1.5868.

Analyse beregnet for 79,22; H, 5,70;Analysis calculated for 79.22; H, 5.70;

Fundet: C, 79,39; H, 5,79.Found: C, 79.39; H, 5.79.

B, g-Methyl-3-nhenoxybenzylalkoholB, g-Methyl-3-nhenoxybenzyl alcohol

En omrørt opløsning af 700 g m-pheuoxyaeetophenon i 3000 ml vandfri methanol afkøledes til 0° C på et is-acetone-bad. Der sattes 136 g (3,6 mol) natriumborhydrid i små portioner til opløsningen med en sådan hastighed, at temperaturen ikke steg over 10°C. Efter at borhydridtilsætningen var til ende, henstod reaktionsblandingen til opvarmning til stuetemperatur og omrørtes i 18 timer. Herpå opvarmedes den under tilbagesvaling og omrøring i 8 timer. Der afdestilleredes ca. 400 ml methanol, og den tilbageværende opløsning inddampedes til ea. en trediedel af det oprindelige volumen i vakuum og udhældtes i isvand. Denne blanding ekstraheredes to gange med ether, gjordes sur med 6N saltsyre og ekstraheredes endnu en gang med either. Etherekstrakterne blandedes, udvaskedes med mættet NaCl-opløsning, tørredes over 16 165778 vandfrit natriumsulfat og inddampes i vakuum. Den olieagtige remanens destilleredes gennem en 15 cm Vigreux-kolonne, hvorved man fik 666 g a-methyl-3-phenoxybenzylalkohol, k.p. 132-134°C. (0,35 mm) njp = 1,5809.A stirred solution of 700 g of m-pheuoxyyaetophenone in 3000 ml of anhydrous methanol was cooled to 0 ° C on an ice-acetone bath. 136 g (3.6 moles) of sodium borohydride were added in small portions to the solution at such a rate that the temperature did not rise above 10 ° C. After the borohydride addition was complete, the reaction mixture was allowed to warm to room temperature and stirred for 18 hours. Then it was heated under reflux and stirring for 8 hours. There were distilled approx. 400 ml of methanol and the remaining solution evaporated to ea. one third of the original volume in vacuo and poured into ice water. This mixture was extracted twice with ether, acidified with 6N hydrochloric acid and extracted again with either. The ether extracts were mixed, washed with saturated NaCl solution, dried over anhydrous sodium sulfate and evaporated in vacuo. The oily residue was distilled through a 15 cm Vigreux column to give 666 g of α-methyl-3-phenoxybenzyl alcohol, b.p. 132-134 ° C. (0.35 mm) njp = 1.5809.

Analyse beregnet for c» 78,48; Ξ, 6,59;Analysis calculated for c »78.48; 6,5, 6.59;

Pundet: C, 78,75; H, 6,31.Pound: C, 78.75; H, 6.31.

0. g-Me thyl-5-phenoxybenzylbromid0. g-Me thyl-5-phenoxybenzyl bromide

En omrørt opløsning af 1357 g a -me thy 1-3 -phenoxybenzyla Ikoho 1 i 5000 ml vandfri CCl^ (fortørret over en molekylsi) afkøledes til 0° C. Hertil sattes 1760 g PBr,, og omrøringen og afkølingenA stirred solution of 1357 g of α-thyme 1-3-phenoxybenzyla Ikoho 1 in 5000 ml of anhydrous CCl 2 (dried over a molecular sieve) was cooled to 0 ° C. To this was added 1760 g of PBr 2, and the stirring and cooling

D QD Q

vedligeholdtes, således at temperaturen forblev på 0-5 0 under tilsætningen. Reaktionsblandingen henstod derpå til opvarmning til stuetemperatur og omrørtes natten over (ca. 12 timer). Reaktionsblandingen hæld te s derpå ud i isvand, og den organiske fase skiltes fra. Ren vandige fase ekstraheredes med 001^ , og de kombinerede ekstrakter udvaskedes 3 gange med vand, tørredes over vandfrit natriumsulfat og inddampedes til tørhed i vakuum, hvorved man fik 1702 g a-methyl-3-phenoxybenzylbromid som en tung, viskos olie, n£5 = 1,5393;was maintained so that the temperature remained at 0-5 0 during the addition. The reaction mixture was then allowed to warm to room temperature and stirred overnight (about 12 hours). The reaction mixture was then poured into ice water and the organic phase separated. Pure aqueous phase was extracted with 001 and the combined extracts were washed 3 times with water, dried over anhydrous sodium sulfate and evaporated to dryness in vacuo to give 1702 g of α-methyl-3-phenoxybenzyl bromide as a heavy viscous oil, n 5 = 1.5393;

Analyse beregnet for C^H-^BrO: 0, 60,44; H, 4,71; Br, '28,73;Analysis calculated for C C ^H BrO Br BrO: 0.60.44; H, 4.71; Br, '28, 73;

Pundet: - 0, 60,62; H, 4,89; Br, 28,47.Pound: - 0, 60.62; H, 4.89; Br, 28.47.

D. 2-(5-Phenoxypheny1)prorionitrilD. 2- (5-Phenoxyphenyl) prorionitrile

En kraftigt omrørt suspension af 316 g 98 fo natriumcyanid i 5000 ml vandfrit dimethylsulfoxid (fortørret over en molekylsi) opvarmedes til 50-60° G, og holdtes ved denne temperatur, medens man langsomt tilsatte 1702 g a-methyl-3-phenoxybenzylbromid. Efter at bromidtilsætningen var til ende, hævedes temperaturen til 75° C, og blandingen omrørtes ved denne temperatur i 1,5 timer. Blandingen henstod til afkøling til stuetemperatur og omrørtes natten over ved stuetemperatur, hvorpå den hældtes ud i isvand.A vigorously stirred suspension of 316 g of 98 µl sodium cyanide in 5000 ml of anhydrous dimethyl sulfoxide (dried over a molecular sieve) was heated to 50-60 ° G and maintained at this temperature while 1702 g of α-methyl-3-phenoxybenzyl bromide was slowly added. After the bromide addition was complete, the temperature was raised to 75 ° C and the mixture was stirred at this temperature for 1.5 hours. The mixture was allowed to cool to room temperature and stirred overnight at room temperature, then poured into ice water.

Ren resulterende vandige suspension ekstraheredes 2 gange med ethylacetat og derpå med ether. Ren organiske ekstrakt udvaskedes 2 gange med en natriumchloridopløsning og 1 gang med vand, og tørredes derpå over vandfri natriumsulfat. Afdampningen af opløsningsmidlet i vakuum efterlod en olieagtig remanens, som destilleredes gennem en 15 cm Tigreux-kolonne, hvorved man fik 1136 g 2-(3-pbenoxyphenyl)propionitril, k.p., 141-148° C (0,1 17 145778 mm), ujjp = 1,5678.Pure resulting aqueous suspension was extracted twice with ethyl acetate and then with ether. Pure organic extract was washed twice with a sodium chloride solution and once with water, and then dried over anhydrous sodium sulfate. Evaporation of the solvent in vacuo left an oily residue which was distilled through a 15 cm Tigreux column to give 1136 g of 2- (3-pbenoxyphenyl) propionitrile, bp, 141-148 ° C (0.1 17 145778 mm), ujjp = 1.5678.

Analyse beregnet for G^E^W: 0, 80,69; H, 5,87; H, 6,27?Analysis calculated for G 2 E 2 W: 0.80.69; H, 5.87; H, 6.27?

Pundet: 0, 80,89 H, 6,10; I, 6,14.Pound: 0, 80.89 H, 6.10; I, 6.14.

S. 2-(3-Phenoxyphenyl)propionsyreS. 2- (3-Phenoxyphenyl) propionic acid

En blanding af 223 g 2-(3-phenoxyphenyl)propionitril og 400 g natriumhydroxid i 1600 ml 50 $6 ethanol opvarmedes under tilbagesvaling og omrøring i 72 timer. Efter afkøling til stuetemperatur udhældtes reaktionsblandingen i isvand. Een resulterende opløsning udvaskedes med ether, gjordes sur med koncentreret HC1 og ekstraheredes med ether. Etherekstrakten udvaskedes med vand, tørredes over vandfrit natriumsulfat.ogginddampedes til tørhed i vakuum. Een olieagtige remanens destilleredes, hvorved man fik 203,5 g (84 1°) 2-(3-phenoxypheny 1 )propionsyre som en viskos olie, k.p., 168-171° C, (0,11 mm), n^ = 1,5742, pK'a = 7,3.A mixture of 223 g of 2- (3-phenoxyphenyl) propionitrile and 400 g of sodium hydroxide in 1600 ml of 50 $ 6 ethanol was heated under reflux and stirring for 72 hours. After cooling to room temperature, the reaction mixture was poured into ice water. A resulting solution was washed with ether, acidified with concentrated HCl and extracted with ether. The ether extract was washed with water, dried over anhydrous sodium sulfate and evaporated to dryness in vacuo. An oily residue was distilled to give 203.5 g (84 1 °) of 2- (3-phenoxyphenyl) propionic acid as a viscous oil, bp, 168-171 ° C, (0.11 mm), n , 5742, pK'a = 7.3.

Analyse beregnet for O-j^H-^O^: C, 74,36: H, 5,83;For C-forH H ^O O: C, 74.36: H, 5.83;

Pundet: C, 74»48; H, 6,05.Pound: C, 74 »48; H, 6.05.

EKSEMPEL 11 2-(3-Phenoxyphenvl)prop ionsyre, natriumsalt. dihvdrat 6460 g 2-(3-Phenoxyphenyl)propionsyre omdannedes til natriumsaltet ved portionsvis tilsætning til 26,7 mol 2SF natriumhydroxid under omrøring og afkøling. Ee vandige opløsninger inddampedes til næsten tørhed i vakuum. Ee halvtørre remanenser omrørtes med ethylacetat og inddampedes atter i vakuum. Ee hvide faste remanenser opløstes i åen ringest mulige mængde kogende ethylacetat, filtreredes ned i en stor .beholder (ca. 18 liter) og henstod natten over ved 7° C. Een resulterende krystallinske masse filtreredes og tørredes i vakuum ved stuetemperatur, hvorved man fik 6954 g ren natrium-2-(3-phenoxyphenyl)-propionat, dihydrat, smp. 76-78° C.EXAMPLE 11 2- (3-Phenoxyphenyl) propionic acid, sodium salt. dihydrate 6460 g of 2- (3-Phenoxyphenyl) propionic acid was converted to the sodium salt by portion addition to 26.7 moles of 2SF sodium hydroxide with stirring and cooling. Aqueous solutions were evaporated to near dryness in vacuo. One half-dry residue was stirred with ethyl acetate and evaporated again in vacuo. One white solid residue was dissolved in the smallest amount of boiling ethyl acetate, filtered into a large vessel (about 18 liters) and left overnight at 7 ° C. A resulting crystalline mass was filtered and dried in vacuo at room temperature to give 6954 g of pure sodium 2- (3-phenoxyphenyl) propionate, dihydrate, m.p. 76-78 ° C.

Analyse beregnet for : C, 59,99? H, 5,70?Analysis calculated for: C, 59.99? H, 5.70?

Pundet: 0, 59,93; H, 5,97.Pound: 0, 59.93; H, 5.97.

14577« 18 EKSEMPEL 12 2- (5-Phenoxyphenyl· )nro-pionamidEXAMPLE 12 2- (5-Phenoxyphenyl ·) nitro-pionamide

En opløsning af 0,5 ii 2-(3-pbeuoxyphenyl)propionylchlorld i 300 ml tør ethylether sattes dråbevis til 2 liter flydende ammoniak under omrøring. Efter at tilsætningen var til ende, omrørtes reaktions blandingen i 1 time, og der tilsattes 500 ml diethylether.A solution of 0.5 µl of 2- (3-pbeuoxyphenyl) propionyl chloride in 300 ml of dry ethyl ether was added dropwise to 2 liters of liquid ammonia with stirring. After the addition was complete, the reaction mixture was stirred for 1 hour and 500 ml of diethyl ether was added.

Reaktionsbiandingen henstod natten over, hvorved overskud af ammoniak -af dampede. Der tilsattes fortyndet saltsyre til reaktionsblandingen, og etherlaget skiltes fra, udvaskedes med natriumhydroxid og vand og tørredes over natriumsulfat. Afdampning af etheren i vakuum efterlod en gummiagtig remanens, som krystalliserede efter triturering med kold hexan. Omkrystallisation fra ethyl-acetat og hexan gav 76,2 g 2-(3-phenoxyphenyl)propionamid, smp. 67-69° 0.The reaction mixture was allowed to stand overnight, thereby evaporating excess ammonia. Dilute hydrochloric acid was added to the reaction mixture and the ether layer was separated, washed with sodium hydroxide and water and dried over sodium sulfate. Evaporation of the ether in vacuo left a gummy residue which crystallized after trituration with cold hexane. Recrystallization from ethyl acetate and hexane gave 76.2 g of 2- (3-phenoxyphenyl) propionamide, m.p. 67-69 ° 0.

Analyse beregnet for : C, 74,66: Ξ, 6,27; E, 5,81;Analysis calculated for: C, 74.66: Ξ, 6.27; E, 5.81;

Pundet: C, 74,01; H, 6,50; E, 6,15.Pound: C, 74.01; H, 6.50; E, 6.15.

EKSEMPEL 15EXAMPLE 15

Il, IT-Dime thy 1 - 2 - ( 5-nhenoxyphenyl )oropionamidII, IT-Dime thy 1-2 - (5-nhenoxyphenyl) oropionamide

Til 400 ml tør chloroform sattes 72,6 g 2-(3-phenoxyphenyl)pro-pionsyre og 56,9 g thionylehlorid. Reaktionsblandingen opvarmedes under tilbagesvaling og omrøring i ca. 5 timer. Chloroformen afdampedes herpå, og remanensen underkastedes 2 gange en azeo-tropisk destillation med benzen. Remanensen opløstes i ethyl-ether og sattes under omrøring og afkøling til en opløsning af 45 g dimethylamin i ethylether. Temperaturen holdtes ved ca.To 400 ml of dry chloroform were added 72.6 g of 2- (3-phenoxyphenyl) propionic acid and 56.9 g of thionyl chloride. The reaction mixture was heated under reflux and stirring for ca. 5 hours. The chloroform was then evaporated and the residue was subjected twice to azeotropic distillation with benzene. The residue was dissolved in ethyl ether and added with stirring and cooling to a solution of 45 g of dimethylamine in ethyl ether. The temperature was kept at approx.

0° 0 eller herunder under tilsætningen. Reaktionsblandingen hen-stod til opvarmning til stuetemperatur, opvarmedes herpå forsigtigt under tilbage svaling i 1,5 timer, hældtes ud i is og vand og gjordes sur, og ethyletherlaget separeredes fra. Det vandige lag ekstraheredes med ethylether. Etherekstrakterne kombineredes, udvaskedes med vand, tørredes over natriumsulfat og inddampedes til et hvidt fast stof. Det faste stof opløstes i kogende hexan og henstod til langsom afkøling til stuetemperatur, hvorved man fik 67,6 g IT,lt-dimethyl-2-(5-phenoxyphenyl)propionamid, smp.0 ° 0 or below during the addition. The reaction mixture was allowed to warm to room temperature, then gently heated under reflux for 1.5 hours, poured into ice and water and acidified and the ethyl ether layer separated. The aqueous layer was extracted with ethyl ether. The ether extracts were combined, washed with water, dried over sodium sulfate and evaporated to a white solid. The solid was dissolved in boiling hexane and allowed to cool to room temperature to give 67.6 g of IT, lt-dimethyl-2- (5-phenoxyphenyl) propionamide, m.p.

73,5-76° C.73.5-76 ° C.

19 14577819 145778

Analyse beregnet for ci7Hi9N02: C, 75,80; H, 7,11; N, 5,20;Analysis calculated for c17 H19 NO2: C, 75.80; H, 7.11; N, 5.20;

Fundet: C, 75,93; H, 6,90; N, 5,27.Found: C, 75.93; H, 6.90; N, 5.27.

EKSEMPEL 14-15EXAMPLES 14-15

De følgende forbindelser fremstilledes analogt med fremgangsmåden ifølge eksempel 13 ud fra passende udgangsmaterialer.The following compounds were prepared analogously to the method of Example 13 from appropriate starting materials.

N-Methyl-2-(3-phenoxyphenyl)butyramid, smp. 84 - 86 °C.N-Methyl-2- (3-phenoxyphenyl) butyramide, m.p. 84 - 86 ° C.

Analyse ber. for C^H^NC^: C, 75,81; H, 7,11; N, 5,20.Analysis calculated. for C ^H ^ NCN₂O: C, 75.81; H, 7.11; N, 5.20.

Fundet: C, 75,60; H 7,11; N, 5,00.Found: C, 75.60; H, 7.11; N, 5.00.

N-Methyl-2-(3-phenoxyphenyl)propionamid, smp. 57 - 58 °C.N-Methyl-2- (3-phenoxyphenyl) propionamide, m.p. 57 - 58 ° C.

Analyse ber. for ci5H17N02: c' 75,27; H, 6,71; N, 5,49.Analysis calculated. for c15 H17 NO2: c '75.27; H, 6.71; N, 5.49.

Fundet: C, 75,51; H, 6,86; N, 5,61.Found: C, 75.51; H, 6.86; N, 5.61.

EKSEMPEL 16EXAMPLE 16

Spaltning af dl-2-(3-phenoxyphenyl)propionsyre 200 g dl-2-(3-phenoxyphenyl)propionsyre fremstillet som i eksempel 10 opløstes i 3000 ml varm ethylacetat, og 100 g d-(+)-^-methyl-benzylamin sattes til opløsningen. Der udskiltes en krystallinsk masse ved afkøling. Denne filtreredes, hvorved man fik 229 g dl-2-(3-phenoxyph8nyl)propionsyre, d- (+)-a-methylbenzylaminsalt, smp. 115-126°C. 5 successive omkrystallisationer fra varm ethylacetat gav 63,5 g d-[+)-2-(3-phenoxyphenyl)propionsyre, d-(+)-a-methyl-benzylaminsalt, smp. 142-144°C, + 14,5° (C = 1$, OHOl^), ZT«+ 5,74 (C = ltf, CH30H).Cleavage of dl-2- (3-phenoxyphenyl) propionic acid 200 g of dl-2- (3-phenoxyphenyl) propionic acid prepared as in Example 10 was dissolved in 3000 ml of hot ethyl acetate and 100 g of d - (+) - ^ - methyl-benzylamine. was added to the solution. A crystalline mass is separated by cooling. This was filtered to give 229 g of dl-2- (3-phenoxyphenyl) propionic acid, d- (+) - α-methylbenzylamine salt, m.p. 115-126 ° C. 5 successive recrystallizations from hot ethyl acetate gave 63.5 g of d - [+) - 2- (3-phenoxyphenyl) propionic acid, d - (+) - α-methyl-benzylamine salt, m.p. 142-144 ° C, + 14.5 ° (C = 1 $, OHOl +), ZT + + 5.74 (C = ltf, CH 3 OH).

Analyse. Ber. for C^H^NO^: C, 76,00; H, 6,93; Η» 3,85·Analysis. Ber. for C ^H ^ NONO:: C, 76.00; H, 6.93; Η »3.85 ·

Pundet: C, 75,72; H 6,80; N, 3,63- På lignende måde fremstilledes 1-(-)-2-(3-phenoxyphenyl)propionsyre, 1-(~)-a-methylbenzylaminsalt, smp. 141-142°C, - 3,63 (C = l/o, CH30H).Pound: C, 75.72; H, 6.80; N, 3.63- Similarly, 1 - (-) - 2- (3-phenoxyphenyl) propionic acid, 1- (~) -α-methylbenzylamine salt, m.p. 141-142 ° C - 3.63 (C = 1 / o, CH 3 OH).

20 145778 52 g d-(+)-2-(3-phenoxyphenyl)propionsyre, d- (+)-a-methylbenzylamin-salt suspenderedes mellem 1,5 1 K^O og 0,5 1 EtgO og gjordes sur ved tilsætning af 6R H01. Etherlaget udvaskedes med vand, tørredes over ITagSO^ og inddampedes i vakuum, hvorved man fik d-(+)-2-(3-phenoxyphenyl)propionsyre, + 46,0 (0 = 1$, CHC13).52 g of d - (+) - 2- (3-phenoxyphenyl) propionic acid, d- (+) - α-methylbenzylamine salt were suspended between 1.5 L of K 2 O and 0.5 L of EtgO and acidified by addition. of 6R H01. The ether layer was washed with water, dried over ITagSO 4 and evaporated in vacuo to give d - (+) - 2- (3-phenoxyphenyl) propionic acid, + 46.0 (0 = 1 $, CHCl 3).

Pål lignende måde fremstilledes 1-(-)-2-(3-phenoxyphenyl)propionsyre, £- 45,7 (O = 1$, OHOlj) ud fra 1-(-)-2-(3-phenoxyphenyl)pro-pionsyre, 1- (-)- α-methylbenzylaminsalt.In a similar manner, 1 - (-) - 2- (3-phenoxyphenyl) propionic acid, δ - 45.7 (O = 1 $, OHOl , 1- (-) - α-methylbenzylamine salt.

EKSEMPEL 17 2-(5-Phenoxyphenvl)smørsyre A. 2- (3- Phenoxyphenyl) butyr onit r il 23 g natrium sattes til 4 1 flydende ammoniak i en 5-liter kolbe, som indeholdt en katalytisk mængde jern (III) chlorid. Reaktions-blandingen omrørtes i ea. 30 minutter. Til den resulterende blanding sattes 209 g 2-(3-phenoxyphenyl)acetonitril, fremstillet som ovenfor under reaktionsskema I. Reaktionsblandingen omrørtes i 30 minutter, og der tilsattes 187,2 g ethyliodid under omrøring. Reaktionsblandingen omrørtes natten over, hvorved ammoniakken fordampede. Per tilsattes vandfri ethylether til remanensen,, .og blandingen gjordes sur med 6R saltsyre og omrørtes i ca. 1 time. Reaktionsblandingen ekstraheredes derpå med ethylether. Etherlaget udvaskedes med vand og natriumthiosulfatopløsning, og etheren afdampedes.EXAMPLE 17 2- (5-Phenoxyphenyl) butyric acid A. 2- (3- Phenoxyphenyl) butyr onit in 23 g of sodium was added to 4 liters of liquid ammonia in a 5-liter flask containing a catalytic amount of iron (III) chloride. The reaction mixture was stirred in ea. 30 minutes. To the resulting mixture was added 209 g of 2- (3-phenoxyphenyl) acetonitrile prepared as above under Scheme I. The reaction mixture was stirred for 30 minutes and 187.2 g of ethyl iodide was added with stirring. The reaction mixture was stirred overnight, evaporating the ammonia. Per anhydrous ethyl ether was added to the residue, and the mixture was acidified with 6R hydrochloric acid and stirred for approx. 1 hour. The reaction mixture was then extracted with ethyl ether. The ether layer was washed with water and sodium thiosulfate solution and the ether was evaporated.

Pen resulterende olieagtige remanens destilleredes, hvorved man fik 155,2 g 2-(3-phenoxyphenyl)butyronitril, k.p. 138-140°C/0,14 mm.Pen resulting oily residue was distilled to give 155.2 g of 2- (3-phenoxyphenyl) butyronitrile, b.p. 138-140 ° C / 0.14 mm.

B- 145 g af den ovenfor fremstillede 2-(3-phenoxyphenyl)butyroni-tril hydrolyseredes til den korresponderende syre, efter fremgangsmåden ifølge eksempel 10 E, hvorved man fik 95,9 g 2-(3-phenoxyphenyl) smørsyre, smp. 73-77°0.B-145 g of the 2- (3-phenoxyphenyl) butyronitrile prepared above was hydrolyzed to the corresponding acid, following the procedure of Example 10E to give 95.9 g of 2- (3-phenoxyphenyl) butyric acid, m.p. 73-77 ° 0th

Analyse. Ber. for O^H^O^: 0, 74,98; H, 6,29»Analysis. Ber. for O ^ H ^ O ^: 0, 74.98; H, 6.29

Pundet: C, 74,70; H, 6,33· 21 145778 EKSEMPEL 18Pound: C, 74.70; H, 6.33 · 21 EXAMPLE 18

Ethvl-2-(5-phenoxvphenvl)propionat 200 g 2-(3-phenoxyphenyl)propionsyre, fremstillet som i eksempel 10, opløstes i 1500 ml ethanol, og der ledtes hydrogenohloridgas ned i den ethanoliske opløsning, indtil den var mættet. Reaktionsblandingen opvarmedes derpå under tilbagesvaling og omrøring natten over, hvorefter en stor del af ethanolen afdampedes i vakuum, og den tilbageværende reaktionsblanding hældtes ud i isvand. Blandingen gjordes basisk med 10$ natriumhydroxid og ekstraheredes 2 gange med ethylether. De kombinerede etherekstrakter udvaskedes 2 gange med vand og tørredes over natriumsulfat<, Ethyletheren afdampedes og efterlod urent ethyl-2-(3-phenoxyphenyl)propionat som en olieagtig remanens. Fremstillingen gentoges med yderligere 200 g 2-(3-phenoxy-phenyl)propionsyre. De urene remanenser kombineredes og destilleredes gennem en 15 cm Vigreux-kolonne, hvorved man fik 339,9 g ethyl- 2- (3-phenoxyphenyl)propionat, k.p. 128-134°0/0,15 mm, = 1,5458.Ethyl 2- (5-phenoxyphenyl) propionate 200 g of 2- (3-phenoxyphenyl) propionic acid, prepared as in Example 10, was dissolved in 1500 ml of ethanol and hydrogen oxide of gas was poured into the ethanolic solution until saturated. The reaction mixture was then heated under reflux and stirring overnight, after which a large part of the ethanol was evaporated in vacuo and the remaining reaction mixture was poured into ice water. The mixture was basified with 10 $ sodium hydroxide and extracted twice with ethyl ether. The combined ether extracts were washed twice with water and dried over sodium sulfate. The ethyl ether was evaporated leaving crude ethyl 2- (3-phenoxyphenyl) propionate as an oily residue. The preparation was repeated with an additional 200 g of 2- (3-phenoxy-phenyl) propionic acid. The crude residues were combined and distilled through a 15 cm Vigreux column to give 339.9 g of ethyl 2- (3-phenoxyphenyl) propionate, b.p. 128-134 ° 0 / 0.15 mm, = 1.5458.

Analyse. Ber. for C17H1803: o, 75,53i H, 6,71.Analysis. Ber. for C17H1803: 0.75.53i H, 6.71.

Fundet: C, 75,75} H, 6,70.Found: C, 75.75} H, 6.70.

EKSEMPEL 19 3- (5-phenoxyphenyl)smørsyre A. Ethyl-3-(3-Phenoxyphenyl)crotonat 224 g triethylphosphonoacetat sattes langsomt til 48 g 50 procent natriumhydriddispersion suspenderet i 500 ml dimethoxyethan linder omrøring. Der tilsattes dråbevis 212 g m-phenoxyacetophenon opløst i 1500 ml dimethoxyethan, og der omrørtes i 1 time. Reaktionsblandingen opvarmedes derpå under tilbagesvaling natten over, afkøledes til stuetemperatur og dekomponeredes ved tilsætning af vand. Efter afdampning af opløsningsmidlet i vakuum opløstes det urene produkt i ethylacetat, udvaskedes to gange med vand og tørredes over natriumsulfat. Inddampning af ethylacetatet efterlod en olieagtig remanens, som destilleredes under dannelse af 52,6 g ethyl-3-(3-phenoxyphenyl)crotonat, k.p., 163-170° C./0,2 mm, τι2^ = 1,5770.EXAMPLE 19 3- (5-Phenoxyphenyl) Butyric Acid A. Ethyl 3- (3-Phenoxyphenyl) Crotonate 224 g of triethylphosphonoacetate was slowly added to 48 g of 50 percent sodium hydride dispersion suspended in 500 ml of dimethoxyethane relieving stirring. 212 g of m-phenoxyacetophenone dissolved in 1500 ml of dimethoxyethane were added dropwise and stirred for 1 hour. The reaction mixture was then heated at reflux overnight, cooled to room temperature and decomposed by adding water. After evaporation of the solvent in vacuo, the crude product was dissolved in ethyl acetate, washed twice with water and dried over sodium sulfate. Evaporation of the ethyl acetate left an oily residue which was distilled to give 52.6 g of ethyl 3- (3-phenoxyphenyl) crotonate, b.p., 163-170 ° C / 0.2 mm, τι2 = 1.5770.

22 145778 B, Ethyl-3-(3-phenoxyphenvl)butyrat 197 g af det ovenfor fremstillede ethyl-3-(3-phenoxyphenyl)crotonat opløst i 400 ml ethanol hydrogeneredes i nærværelse af platinoxid. Ethanolen inddampedes i vacuum efterladende en olieagtig remanens som destilleredes, hvorved man fik 160 g ethyl-3-(3-phenoxyphenyl) butyrat, k,p. , 137-139°C./0,06 mm, n^5 = 1,5401.Ethyl 3- (3-phenoxyphenyl) butyrate 197 g of the above-prepared ethyl 3- (3-phenoxyphenyl) crotonate dissolved in 400 ml of ethanol was hydrogenated in the presence of platinum oxide. The ethanol was evaporated in vacuo leaving an oily residue which was distilled to give 160 g of ethyl 3- (3-phenoxyphenyl) butyrate, k, p. , 137-139 ° C / 0.06 mm, n ^ 5 = 1.5401.

C. 3- (5-phenoxyphenvl) smørsyre 160 g af det ovenfor fremstillede ethyl-3-(3-phenoxyphenyl)butyrat hydrolyseredes som i eksempel 10E, hvorved man fik 117,2 g 3-(3-phen-oxyphenyl)smørsyre, k,p. f 193-195°C/0,23 mm, nD25= 1,5687, pK'a = 7,2. Analyse, Ber. for ci6^lSQy C* 74,98; H 6,29C. 3- (5-phenoxyphenyl) butyric acid 160 g of the above-prepared ethyl 3- (3-phenoxyphenyl) butyrate was hydrolyzed as in Example 10E to give 117.2 g of 3- (3-phenoxyphenyl) butyric acid. k, P. f 193-195 ° C / 0.23 mm, nD25 = 1.5687, pK'a = 7.2. Analysis, Ber. for C16 H15 Cl2 C * 74.98; H, 6.29

Fundet : C, 75»18; H 6,41 EKSEMPEL 20Found: C, 75 »18; H 6.41 Example 20

Fremstilling af 2-(3-phenoxyphenyl)propionsyre ved decarboxylering af en dicarboxylsyre A. Fremstilling af ethyl-2-(3-phenoxyphenyl)-acetat.Preparation of 2- (3-phenoxyphenyl) propionic acid by decarboxylation of a dicarboxylic acid A. Preparation of ethyl 2- (3-phenoxyphenyl) acetate.

Tør HCl-gas bobledes igennem en opløsning af 257 g 3-phenoxyphenyled-dikesyre, fremstillet som angivet i eksempel 1, i 1500 ml ethanol indtil mætning. Blandingen blev opvarmet under tilbagesvaling og omrøring i 3 timer og derefter påny mættet med HCl-gas. Der opvarmedes under tilbagesvaling natten over. Efter afkøling blev blandingen delvis inddampet i vacuum og udhældt i isvand. Det olieagtige produkt blev ekstraheret over i ether, og etheropløsningen blev-vasket med vand og en 5% natriumbicarbonatopløsning og tørret over natriumsulfat. Afdampning af etheren i vacuum og destillation af den olieagtige rest gav 256 g ethyl-2-(3-phenoxyphenyl)-acetat med kogepunkt 140-146°C (10,1 mm). N§5,5= 1,5520.Dry HCl gas is bubbled through a solution of 257 g of 3-phenoxyphenylacetic acid, prepared as in Example 1, in 1500 ml of ethanol until saturation. The mixture was heated under reflux and stirring for 3 hours and then saturated with HCl gas again. It was refluxed overnight. After cooling, the mixture was partially evaporated in vacuo and poured into ice water. The oily product was extracted into ether and the ether solution was washed with water and a 5% sodium bicarbonate solution and dried over sodium sulfate. Evaporation of the ether in vacuo and distillation of the oily residue yielded 256 g of ethyl 2- (3-phenoxyphenyl) acetate at boiling point 140-146 ° C (10.1 mm). N§ 5.5 = 1.5520.

Analyse beregnet for C-yÆ^O^: C 74,98; H 6,29Analysis calculated for C-y-yO ^: C, 74.98; H, 6.29

Fundet : C 75,16; H 6,21 B. Fremstilling af diethyl-2-methy1-2-(3-phenoxyphenyl)malonat.Found: C, 75.16; H 6.21 B. Preparation of diethyl-2-methyl-2- (3-phenoxyphenyl) malonate.

En blanding af 128 g ethyl-2-(3-phenoxyphenyl)-acetat og 300 ml 23 145778 diethylcarbonat blev omrørt og opvarmet til omkring 110°C, mens 11,5 g metallisk natrium i klumper på størrelse med ærter blev tilsat i løbet af 90 minutter. En del ethanol og diethylcarbonat destillerede bort under tilsætningen af natrium. Efter fuldstændig tilsætning af natrium blev reaktionstemperaturen forøget, indtil damptemperaturen var nået op på 130°C. Blandingen blev afkølet til 15°C i et isbad, og der blev dråbevis i løbet af 15 minutter tilsat 60 ml methyliodid. Blandingen blev opvarmet til 80°C i en time. Efter afkøling tilsattes en lille smule vand, og blandingen udhældtes i isvand, gjordes sur med HC1 og ekstraheredes med ether. Étherekstrakten blev tørret over natriumsulfat og inddampet i vacuum. Den tiloversblevne væske blev destilleret igennem en 15 cm Vigreux-kolonne, hvilket gav 100,2 g diethyl-2-methyl-2(3-phenoxyphenyl)malonat med kogepunkt 155-175°C (10,1 mm); Ng3’5=l,5337.A mixture of 128 g of ethyl 2- (3-phenoxyphenyl) acetate and 300 ml of diethyl carbonate was stirred and heated to about 110 ° C, while 11.5 g of metallic sodium in pea-sized chunks was added over 90 minutes. Some ethanol and diethyl carbonate distilled away during the addition of sodium. After complete addition of sodium, the reaction temperature was increased until the vapor temperature reached 130 ° C. The mixture was cooled to 15 ° C in an ice bath and 60 ml of methyl iodide was added dropwise over 15 minutes. The mixture was heated to 80 ° C for one hour. After cooling, a small amount of water was added and the mixture was poured into ice water, acidified with HCl and extracted with ether. The ether extract was dried over sodium sulfate and evaporated in vacuo. The remaining liquid was distilled through a 15 cm Vigreux column to give 100.2 g of diethyl-2-methyl-2 (3-phenoxyphenyl) malonate at boiling point 155-175 ° C (10.1 mm); Ng3'5 = l, 5337th

Analyse beregnet for ^20^22^5; c 70,16; H 6,48Analysis calculated for ^ 20 ^ 22 ^ 5; c, 70.16; H, 6.48

Fundet ; C 70,40; H 6,27.Found; C, 70.40; H, 6.27.

C. Fremstilling af 2-methyl-2-(3-phenoxyphenyl)malonsyre.C. Preparation of 2-methyl-2- (3-phenoxyphenyl) malonic acid.

En opløsning af 57 g diethyl-2-methyl-2-(3-phenoxyphenyl)malonat og 40 g natrium-hydroxid i 300 ml 50% (v/v) vandig ethanol blev omrørt og opvarmet under tilbagesvaling natten over. Blandingen blev udhældt i isvand og vasket med ether til fjernelse af ikke hydrolyseret ester. , Den vandige fase blev gjort sur med koncentreret HC1 og ekstraheret med ether. Etherekstrakten blev tørret over natriumsulfat og inddampet i vacuum til opnåelse af 44 g 2-methyl-2-(3-phenoxyphenyl)malon-syre. Smeltepunkt: 138-143°C (dekomponering under gasudvikling).A solution of 57 g of diethyl-2-methyl-2- (3-phenoxyphenyl) malonate and 40 g of sodium hydroxide in 300 ml of 50% (v / v) aqueous ethanol was stirred and heated under reflux overnight. The mixture was poured into ice water and washed with ether to remove non-hydrolyzed ester. The aqueous phase was acidified with concentrated HCl and extracted with ether. The ether extract was dried over sodium sulfate and evaporated in vacuo to give 44 g of 2-methyl-2- (3-phenoxyphenyl) malonic acid. Melting point: 138-143 ° C (decomposition during gas evolution).

Analyse beregnet for C-^gH^O^: C 67,13; H 4,93Analysis calculated for C C CHHO O: C, 67.13; H, 4.93

Fundet : C 67,37; H 5,23.Found: C, 67.37; H, 5.23.

D. Fremstilling af 2-(3-phenoxyphenyl)propionsyre.D. Preparation of 2- (3-phenoxyphenyl) propionic acid.

15 g 2-methyl-2-(3-phenoxyphenyl)malonsyre blev opvarmet til 130-160°C og omrørt, indtil den voldsomme (^-udvikling ophørte. Efter afkøling til stuetemperatur opnåedes 12,2 g 2-(3-phenoxyphenyl)propion-syre med et NMR-spektrum identisk med spektret for den i eksempel 10E fremstillede forbindelse. N^= 1,5729.15 g of 2-methyl-2- (3-phenoxyphenyl) malonic acid were heated to 130-160 ° C and stirred until the violent (ling evolution ceased. After cooling to room temperature, 12.2 g of 2- (3-phenoxyphenyl) was obtained). propionic acid having an NMR spectrum identical to the spectrum of the compound prepared in Example 10E N = 1.5729.

Analyse beregnet for C 74,36; H 5,82Analysis calculated for C, 74.36; H, 5.82

Fundet : C 74,07; H 5,81.Found: C, 74.07; H, 5.81.

24 14577824 145778

De omhandlede forbindelser kan anvendes til fremstilling af farmaceutiske midler på kendt måde. Som aktiv bestanddel anvendes mindst én af de omhandlede forbindelser i kombination med et egnet bærestof eller fortyndingsmi idel. Forbindelserne udviser både oral og parenteral virkning og kan formuleres på passende måde til oral, parenteral, rektal eller topisk indgivelse.The present compounds may be used to prepare pharmaceutical agents in known manner. At least one of the compounds of this invention is used in combination with a suitable carrier or diluent. The compounds exhibit both oral and parenteral action and may be formulated appropriately for oral, parenteral, rectal or topical administration.

En række af de omhandlede forbindelser er blevet testet for antiin-flamraatorisk virkning i en erythema-blokeringstest på følgende måde:A number of the compounds of this invention have been tested for anti-inflammatory action in an erythema-blocking test as follows:

Der benyttes en metode, som er en modifikation af den af C.V.Winder et al. beskrevne metode (C.V. Winder, V. Burr og C.E. Posiere; "A Study og Pharmacological Influences on Ultraviolet Erythrea in Guinea Pigs”, Arch. Int. Pharmacodyn., 116. 261, 1958). Ved denne metode anvendes marsvin (albinoer) af begge køn med en vægt på 2.25-300 g. Marsvinene barberes på ryggen og depilleres kemisk (NAIR Lotion Hair Remover, Carter Products, N.Y., N.Y.). Efter 18 til 20 timers forløb udsættes dyrene for ultraviolet bestråling efter at have fastet natten over. Umiddelbart efter behandlingen med en af de omhandlede forbindelser anbringes et beskyttende stykke selvklæbende papir på ryggen af dyrene, hvorefter de udsættes for ultraviolet bestråling med høj intensitet i 7 sekunder. Den ultraviolette lyskilde anbringes i kontakt med huden på ryggen af dyrene. Derefter fjernes det beskyttende papir, og marsvinenes rygge renses med en gazetampon dyppet i vand. Det stykke af huden, som har været beskyttet af papiret, virker som et kontrastområde ved bedømmelsen af den dannede erythema. Dyrene anbringes i holdere af gennemsigtig plastik. Efter 60, 90, 120 og 150 minutters forløb, bedømmes graden af den resulterende erythema efter et arbitrært pointsystem, som er baseret på graden.af kontrast og dannet rødme. Anti-inflamatoriske midler forsinker udviklingen af erythema og har derfor størst virkning ved de første bedømmelser. Derfor af-vejes bedømmelserne med en faktor 4, 3, 2 og 1 ved bedømmelse efter henholdsvis 60, 90, 120 og 150 minutter. Den dannede erythema bedømmes på følgende måde: 25 145778A method is used which is a modification of that of C.V.Winder et al. described method (CV Winder, V. Burr and C. Posiere; "A Study and Pharmacological Influences on Ultraviolet Erythrea in Guinea Pigs", Arch. Int. Pharmacodyn., 116, 261, 1958). This method uses guinea pigs (albinos) by Both sexes weigh 2.25-300 g. The guinea pigs are shaved on the back and chemically distilled (NAIR Lotion Hair Remover, Carter Products, NY, NY) After 18 to 20 hours, the animals are exposed to ultraviolet radiation after fasting overnight. Immediately after the treatment with one of the compounds of the present invention, a protective piece of adhesive paper is applied to the animals' backs and then exposed to high-intensity ultraviolet radiation for 7 seconds, and the ultraviolet light source is placed in contact with the skin on the backs of the animals. paper, and the guinea pigs' back is cleaned with a gauze tampon dipped in water. hema. The animals are placed in transparent plastic holders. After 60, 90, 120 and 150 minutes, the degree of the resulting erythema is judged by an arbitrary point system based on the degree of contrast and redness formed. Anti-inflammatory agents delay the development of erythema and therefore have the greatest effect on initial assessments. Therefore, the judgments are weighed by a factor of 4, 3, 2 and 1 when judged after 60, 90, 120 and 150 minutes respectively. The erythema formed is evaluated as follows:

Bedømmelsessystem for erythema Bedømmelse Udseende af behandlet område 0 Ingen rødmen og ingen kontrast 1 Let rødmen med svagt omrids af beskyttelsespapiret 2 Let til moderat rødmen med tydeligt omrids 3 Udpræget rødmen med tydeligt cirkulært omridsErythema Assessment System Assessment Appearance of treated area 0 No redness and no contrast 1 Light redness with slight outline of the protective paper 2 Light to moderate redness with clear outline 3 Distinct redness with clear circular outline

Den totale bedømmelse fra hver gruppe af behandlede dyr (5 eller 6 marsvin i hver gruppe) sammenlignedes med en kontrolgruppe, og den procentvise inhibering beregnes efter følgende formel: 100 x Kontrol - Behandlet . prooent lnhlberlng kontrolThe total assessment from each group of treated animals (5 or 6 guinea pigs in each group) was compared to a control group and the percentage inhibition calculated according to the following formula: 100 x Control - Treated. prooent lnhlberlng control

Testforbindelserne fremstilles i en suspension af 1% methylcellulose i vand og indgives oralt. Marsvinene behandles oralt med 1 ml suspension per. kg legemsvægt. Kontroldyrene behandles med 1 ml pr. kg. legemsvægt af en 1% suspension af methylcellulose. Den dosering i mg pr. kg, som bevirker en 50 % inhibering af det erythemiske respons (ED^q) er anført i den efterfølgende tabel I for en række af de omhandlede forbindelser:The test compounds are prepared in a suspension of 1% methyl cellulose in water and administered orally. Guinea pigs are treated orally with 1 ml suspension per. kg body weight. Control animals are treated with 1 ml per day. kg. body weight of a 1% suspension of methyl cellulose. The dosage in mg per kg, which causes a 50% inhibition of the erythemic response (ED ED q) is listed in the following Table I for a number of the compounds concerned:

TABEL ITABLE I

26 145778 „ Y r_ Z Erythema-bloker ingst e st Y1 2 1 Oral ED50 _ _ (mg. f orbindel se /kg legemsvægt)26 145778 "Y r_ Z Erythema block insertion Y1 2 1 Oral ED50 _ (mg. Bandage per kg body weight)

Tv! > \— / ch-z Y2 ~ Η H CH^ COONa 0,9 Η H CH^ COOCa 1,0 0 Η H CH3 -CNH2 3 0 Η H CH3 -CNHCH3 30 0 Η H CH3 -CN(CH3)2 25 0 Η H CH3 -CNHOH 2TV! > \ - / ch-z Y2 ~ Η H CH ^ COONa 0.9 Η H CH ^ COOCa 1.0 0 Η H CH3 -CNH2 3 0 Η H CH3 -CNHCH3 30 0 Η H CH3 -CN (CH3) 2 25 0 Η H CH 3 -CNHOH 2

OISLAND

Η H CH3 -CNHCH2C00H 5Η H CH3 -CNHCH2C00H 5

Aspirin 50 p-phenoxyphenyleddikesyre (US patentskrift nr. 3 385 886) 29 2-p-phenoxypropionsyre n ς (US patentskrift nr. 3 385 886)Aspirin 50 p-phenoxyphenylacetic acid (U.S. Patent No. 3,385,886) 29 2-p-Phenoxypropionic Acid n (U.S. Patent No. 3,385,886)

Natriumsaltet af 2-(4-phenoxyphenyl)propionsyre (forbindelse A) og natriumsaltet af dl-2-(3-phenoxyphenyl)propionsyre (forbindelse B) blev undersøgt med hensyn til indvirkningen på syresekretionen og læderingen af maveslimhinden hos pylorus-afsnørede rotter; se f.eks.The sodium salt of 2- (4-phenoxyphenyl) propionic acid (Compound A) and the sodium salt of dl-2- (3-phenoxyphenyl) propionic acid (Compound B) were examined for the effect on the acid secretion and gastric mucosal learning of pylorus-laced rats; see e.g.

H. Shay et. al., "A simple method for the Production af Gastric Ulceration in the Rat", Gastroenterology 5, 43-61 (1945) og T. Lin et. al., "3-β-Aminoethyl-1,2,4-triazole, A potent Stimulant of Gastric Secretion", J. Pharmacol, and Exp. Therapy 154, 88-94 (1961).H. Shay et. al., "A Simple Method for the Production of Gastric Ulceration in the Rat", Gastroenterology 5, 43-61 (1945) and T. Lin et. al., "3-β-Aminoethyl-1,2,4-triazole, A potent Stimulant of Gastric Secretion", J. Pharmacol, and Exp. Therapy 154, 88-94 (1961).

27 14577827 145778

De ovennævnte forbindelser blev undersøgt på Harlan-hanrotter, der vejede 150 g. Efter at have fastet i 48 timer fik rotterne deres maver skåret op langs midten, og pylorus blev afsnørret -under let etherbedøvelse. Forbindelserne blev indgivet oralt i doser på 5» 10 og 25 mg/kg til 10 rotter for hver dosis umiddelbart efter operationen. Hvert dyr blev aflivet 3 timer efter indgivelsen af medikamentet .The above compounds were tested on male Harlan rats weighing 150 g. After fasting for 48 hours, the rats had their abdomen cut along the middle and the pylorus was laced - under light ether anesthesia. The compounds were administered orally at doses of 5 »10 and 25 mg / kg to 10 rats for each dose immediately after surgery. Each animal was sacrificed 3 hours after administration of the drug.

Prøver af maveindholdet blev udtaget og analyseret for volumen og total surhedsgrad (op til pH 7), hvorefter maverne omgående blev undersøgt for læsioner og sårdannelser.Stomach contents were sampled and analyzed for volume and total acidity (up to pH 7), and the stomachs were immediately examined for lesions and ulcerations.

Sårdannelsen blev bedømt efter et arbitært poinsystem, som tager følgende karakteristika i betragtning: 1. størrelse og antal af sår 2. grad af nedbrydning 3. blødning og ødem 4. procentdel af rotter med sår o.l.Wound formation was assessed according to an arbitrary point system that takes into account the following characteristics: 1. size and number of wounds 2. degree of degradation 3. bleeding and edema 4. percentage of rats with wounds and the like.

De tildelte point for behandlede rotter sammenlignedes med de tildelte point for kontrolrotterne, og der opnåedes følgende resultater: 1. Indvirkning på syresekretionen:The points awarded for treated rats were compared with the allocated points for the control rats and the following results were obtained: 1. Impact on the acid secretion:

De procentvise ændringer i sekretionen (volumen) over en periode på 3 timer og syrekoncentrationen hos kontroldyr og behandlede dyr fremgår af tabel II:The percent changes in secretion (volume) over a period of 3 hours and the acid concentration in control animals and treated animals are shown in Table II:

TABEL IITABLE II

dosis Antal rotter forbind. forbind.dose Number of rats bandaged. conn.

(mg/kg P.O.) pr. gruppe A B(mg / kg P.O.) per group A B

5 10 + 9 % - 9 %) 10 10 -15 % -20 % r volumen 25 10 0 % 1%) 5 10 - 5 % - 5 %) syre- 10 10 - 6 % -15 koncen- 25 10 - 3 % -7 %J tration 28 145778 2. Indvirkning på læderingen af maveslimhinden.5 10 + 9% - 9%) 10 10 -15% -20% r volume 25 10 0% 1%) 5 10 - 5% - 5%) acid 10 10 - 6% -15 concentration 25 10 - 3 % -7% J tration 28 145778 2. Impact on the lining of the gastric mucosa.

TABEL IIITABLE III

dosis Antal rotter forbindelse A forbindelse Bdose Number of rats compound A compound B

(mg/kg P.O.) pr. gruppe point % ændring point % ændring 5 10 9,41 + 6,7 8,56 - 2,9 10 10 12,46 +41,2 8,18 - 7,3 25 10 15,01 +70,1 6,93 -21,5 kontrol 10 8,82 8,82(mg / kg P.O.) per group points% change points% change 5 10 9.41 + 6.7 8.56 - 2.9 10 10 12.46 +41.2 8.18 - 7.3 25 10 15.01 +70.1 6, 93 -21.5 control 10 8.82 8.82

Endelig blev der foretaget sammenligning imellem meta-pbenoxypheny1-alkansyrer og de tilsvarende para-forbindelser, idet disse, syrer parvis blev undersøgt ved den i det foregående beskrevne metode til bedømmelse af erythema fremkaldt af ultraviolet bestråling. Tabel IV angiver de undersøgte forbindelser, og de opnåede resultater fremgår af tabel V.Finally, comparisons were made between meta-pbenoxyphenyl-1-alkanoic acids and the corresponding para compounds, these acids being pairwise examined by the method described above for the evaluation of erythema induced by ultraviolet radiation. Table IV lists the compounds studied and the results obtained are shown in Table V.

TABEL IVTABLE IV

29 14577829 145778

Undersøgte forbindelser Forbindelse Substitution Syre 53858 META Propionsyre ft \θ~\yCompounds Investigated Compound Substitution Acid 53858 META Propionic Acid ft \ θ ~ \ y

'k=^ '^^^CH-COOH CHCH = COOH CH

70391 PARA Propionsyre C-H-COOH70391 PARA Propionic acid C-H-COOH

~ CH3 53488 META Eddikesyre~ CH3 53488 META Acetic Acid

'==TH2C00H'== TH2C00H

33656 PARA Eddikesyre _CHgCOOH33656 PARA Acetic Acid _CHgCOOH

69II5 META Smørsyre69II5 META Butyric acid

^CH-COOH^ CH-COOH

_^CH2-CH3_ ^ CH2-CH3

62792 PARA Smørsyre ft \~oft y—CH-CQØH62792 PARA Butyric Acid ft \ ~ Often y — CH-CQOH

ch2-ch3 69353 META Valerianesyre ft \ch2-ch3 69353 META Valerian Acid ft \

'^'CH-COOH'^' CH-COOH

CH2-CH2-CH3CH2-CH2-CH3

62813 PARA Valerianesyre ft \W)-// ^_CH-COOH62813 PARA Valeric Acid ft \ W) - // ^ _CH-COOH

~ ch2-ch2-ch3 I 30 145778 £ d ω i ρ cd ft Φ~ ch2-ch2-ch3 I 30 145778 £ d ω i ρ cd ft Φ

PP

•H• H

«Η ρ ω o s CH -ri rj φ«Η ρ ω o s CH -ri rj φ

.j n OHVD ΟΟΛ<|- LT\ IM N H in W O H O US.j n OHVD ΟΟΛ <| - LT \ IM N H in W O H O US

·> Ch -d- vo m vo oo c\i in is ns <|- vo H m m s·> Ch -d- vo m vo oo c \ i in is ns <| - vo H m m s

S SS S

ctf Ή s * ω O d il φ bO i-f g.^ +) ^ in in in co vo vo minus νΟ'Ό'Ό us ics m us φ Η ^ d >> ϋ η ^ <τ3 -Ρ ·η £5 ί>> -ρ 2 ρω (Ρ φ ι ^ cd bo φ φ ·η\ mmmrooo ns ο ο ο ρ g BbjniSN moo ns ο ο ο m oS ·*·*·* ·ν·»·ν λ ·* ·» λctf Ή s * ω O d il φ bO if g. ^ +) ^ in in a co vo vo minus νΟ'Ό'Ό us ics m us φ Η ^ d >> ϋ η ^ <τ3 -Ρ · η £ 5 ί >> -ρ 2 ρω (Ρ φ ι ^ cd bo φ φ · η \ mmmrooo ns ο ο ρ g BbjniSN moo ns ο ο m oS · * · * · * · ν · »· ν λ · * · »Λ

ο Ρ P'S· Ο Ο Μ OHtn Ο Ο Q Ο Ο Ο Ο Η NS CJSο Ρ P'S · OHtn Ο Ο Q Ο Ο Ο Ο NS CJS

[30 iHC\J<f*HC\J<r *9 Η £ Η Η 0 ·[30 iHC \ J <f * HC \ J <r * 9 Η £ Η Η 0 ·

cd Ή ιΗ ιΗ 'Ό JMcd Ή ιΗ ιΗ 'Ό JM

-ρρ,αςη cn m m σν ©cd Ρ NS NS νΰ *£ £ η ft ο ο ο ns ns cm ø pH t— c^- ns ns vo •η d > φ-ρρ, αςη cn m m σν © cd Ρ NS NS νΰ * £ £ η ft ο ο ο ns ns cm ø pH t— c ^ - ns ns vo • η d> φ

cd -Pcd -P

p d ω -ρ ω d Η ·Ηp d ω -ρ ω d Η · Η

d ·Η Pd · Η P

ch-p Jo σ» h <f- m m s is ni o q\ -i co ts· p s- (j i) -h -d-is- cm is- go ns us os <t ifl co cm -d- is- co bO © p!ch-p Your σ »h <f- mms is neither oq \ -i co ts · p s- (ji) -h -d-is- cm is- go ns us os <t ifl co cm -d- is- co bO © p!

d d -Hd d -H

Ή -PΉ -P

Ρ -H ^ ^¾.Ρ -H ^^ ¾.

φ -P 2 ϋ ω π •Hi! S Η (Η ¢3 Ή ω -ρ ρ m m m vovdvd usmus Ό vo co mmmm ω φφ -P 2 ϋ ω π • Hi! S Η (Η ¢ 3 Ή ω -ρ ρ m m m vovdvd usmus Ό vo co mmmm ω φ

•Η P• Η P

t> S, —' -ρω bo 0_ι ra m φ >, ·η\ us us us ns ο ο ^ g ο ο od ω bo cm is- cm nsoo nsooo OØ OSa·'·'·' ·» ·» ^ λλλλt> S, - '-ρω bo 0_ι ra m φ>, · η \ us us ns ο ο ^ g ο ο od ω bo cm is- cm nsoo nsooo OØ OSa ·' · '·' · »·» ^ λλλλ

P i} Q^_/ Ο Ο CM Ο Η NS Ο Ο Ο Ο Ο Ο Ο Η NS OSP i} Q ^ _ / Ο Ο CM Ο Η NS Ο Ο Ο Ο Ο Ο Η NS OS

ρ ] ο j ι—1 CM -d" ι—I CM -d" > td dρ] ο j ι — 1 CM -d "ι — I CM -d"> td d

J ·Η CO 00 00 00 HJ · Η CO 00 00 00 H

m ,h us m oo oo h 3 p co co -d -d eft 3 o ns ns ns ns os e-Ι fern us us lcs vo 145778 31m, h us m oo oo h 3 p co co -d -d eft 3 o ns ns ns ns os e-Ι fern us us lcs vo 145778 31

faOFAO

riri

•H• H

!ri Φ rQ (O 00 O H CM H CM H CM CM CM CTi •H C\1 in N H W 4 ifl H W 4 in s *h i-l! ri Φ rQ (O 00 O H CM H CM H CM CM CM CTi • H C \ 1 in N H W 4 ifl H W 4 in s * h i-l

cOcO

-μ ri in in in in m m ιλ in in m m in-µ ri in in in in m m ιλ in in m m in

pSpS

ω ,¾ •h\ ro o o o ω &c m o o o m m o o m o o o Q £3 Ψ\ ws 9% *\ r\ Ψ* r* f\ ft *> nω, ¾ • h \ ro o o o ω & c m o o m m o o m o o Q £ 3 w \ ws 9% * \ r \ Ψ * r * f \ ft *> n

Qw O H K\ <J\ H KUO CM H ru ^0 CMQw O H K \ <J \ H KUO CM H ru ^ 0 CM

Η HΗ H

• cj •h cm ro ro• cj • h cm ro ro

,Ω Øn Η H, Ω Island Η H

ri IS CO COri IS CO CO

O CM CM CMO CM CM CM

Pn CO CO COPn CO CO CO

bObO

riri

♦H♦ H

riri

(D(D

fit CM-4-COCh roooco OHIOINfit CM-4-COCh roooco OHIOIN

•H CM'iCDIS CM 4 in CD CM <T in CO• H CM'iCDIS CM 4 in CD CM <T in CO

•H• H

NONO

HH

COCO

<j-pri in in in in n in in in m in m in<j-pri in in in in n in in in m in m in

g SUg SU

✓~v| ^-v| -μ tt CO ra ^1 CQ ·Η^> to o O O ίο lo -μ rab£ roooo N m o o t>- in o o ri OS - - - ~ - - - - - - - -✓ ~ v | ^ -V | -µ tt CO ra ^ 1 CQ · Η ^> to o O O ίο lo -µ rab £ roooo N m o o t> - in o o ri OS - - - ~ - - - - - - - -

O f=]Oj OHtOCn o H ro CO OHIOCOO f =] Oj OHtOCn o H ro CO OHIOCO

'HH

> tO> tO

ri ►4 h in ro ro W ,o H in in CQ ri H ro ro <! o on on onri ►4 h in ro ro W, o H in a CQ ri H ro ro <! o on on on

EH ti CO CO COEH ti CO CO CO

Claims (1)

32 145778 Analogifremgangsmåde til fremstilling af 3-phenoxyphenylalkansy-re-derivater med den almene formel Y 2 Y1 - (σιΛ"ζ (« hvori: Y"*· betegner hydrogen, halogen, C-^-C^ alkyl eller C^-C^ alkoxy; betegner hydrogen, halogen, methyl eller ethyl, idet Y^ betegner hydrogen, hvis Y^ er alkoxy, R* betegner hydrogen eller C^-C^ alkyl, n er lig 0 eller 1, og Z betegner: 2 2 (a) -COOR , hvori R betegner hydrogen, C^-C^ alkyl eller et alkalimetal eller jorda1kalimetal; eller (b) R3 -COH^ X3 3 hvori hvert R er ens eller forskellige og betegner hydrogen, hydroxy, methyl eller -CH^COOH, i racemisk eller i d- eller 1-form, kendetegnet ved, at man til fremstilling af forbindelser, hvori Z er -COOH, (a) hydrolyserer en nitril med formlen: R1 i Ar-CH-(CH2)n-CN, 145778 33 hvor R1 og n har den ovenfor angivne betydning, mens Ar her og i det følgende betegner gruppen Y2 γ! J-, (b) decarboxylerer en dicarboxylsyre med formlen: Ar - C(C00H)„ i ^ R1 hvori R^· har den ovenfor angivne betydning, til fremstilling af en forbindelse, hvori n er 0; (c.) opvarmer en keton med formlen: 0 n Ar-C-(CH2)n-CH3 med svovl og morpholin og hydrolyserer det resulterende thioamid til fremstilling af en forbindelse, hvori R1 er hydrogen, eller (d) omsætter et aldehyd eller en keton med formlen: Ar-C=0 i R1 hvori R^ har den ovenfor angivne betydning, med triethylphosphon-acetat, hydrogenerer det således dannede produkt katalytisk, og hydrolyserer den resulterende ester til den tilsvarende syre, hvori n er 1,32 145778 Analogous Process for Preparation of 3-Phenoxyphenylalkanoic Acid Derivatives of the General Formula Y 2 Y1 - (σιΛ "ζ (« wherein: Y "* · represents hydrogen, halogen, C 1 -C 6 alkyl or C 1 -C represents hydrogen, halogen, methyl or ethyl, Y being hydrogen if Y 1 is alkoxy, R * is hydrogen or C 1 -C 6 alkyl, n is 0 or 1, and Z is: 2 2 ( a) -COOR wherein R represents hydrogen, C 1 -C 4 alkyl or an alkali metal or alkaline earth metal, or (b) R 3 -COH 2 X 3 wherein each R is the same or different and represents hydrogen, hydroxy, methyl or -CH COOH, in racemic or in d or 1 form, characterized in that for the preparation of compounds wherein Z is -COOH, (a) hydrolyzes a nitrile of the formula: R 1 in Ar-CH- (CH 2) n-CN Wherein R1 and n have the meaning given above, while Ar here and hereinafter represents the group Y2 γ! J-, (b) decarboxylates a dicarboxylic acid of the formula: Ar - C (C00H) · Has it on top for specified meaning, for the preparation of a compound in which n is 0; (c.) heats a ketone of the formula: 0 n Ar-C- (CH 2) n-CH 3 with sulfur and morpholine, and hydrolyzes the resulting thioamide to produce a compound wherein R 1 is hydrogen, or (d) converts an aldehyde or a ketone of the formula: Ar-C = O in R 1 wherein R 1 is as defined above, with triethyl phosphone acetate, catalytically hydrogenates the product thus formed and hydrolyzes the resulting ester to the corresponding acid wherein n is 1,
DK436169A 1968-08-15 1969-08-14 ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES DK145778C (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DK240577A DK141439B (en) 1968-08-15 1977-06-01 Analogous process for the preparation of 3-phenoxyphenylalkylamine compounds or acid addition salts thereof.
DK240477A DK240477A (en) 1968-08-15 1977-06-01 ANALOGICAL PROCEDURE FOR THE PREPARATION OF 3-PHENOXYPHENYLALKYLTETRAZOLE COMPOSITIONS OR ACID ADDITIONAL SALTS THEREOF
DK240677A DK144760C (en) 1968-08-15 1977-06-01 METHOD OF ANALOGUE FOR THE PREPARATION OF PHENOXYPHENYL ALKANOLS OR ESTERS THEREOF

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US75280168A 1968-08-15 1968-08-15
US75280068 1968-08-15
US75280168 1968-08-15
US752800A US3649679A (en) 1968-08-15 1968-08-15 Substituted phenylalkanoic acid derivatives ii
US82875669 1969-05-28
US828756A US3600437A (en) 1969-05-28 1969-05-28 Substituted phenylalkanoic acids and derivatives thereof

Publications (2)

Publication Number Publication Date
DK145778B true DK145778B (en) 1983-02-28
DK145778C DK145778C (en) 1983-08-22

Family

ID=27419433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK436169A DK145778C (en) 1968-08-15 1969-08-14 ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES

Country Status (16)

Country Link
JP (2) JPS5144938B1 (en)
AR (1) AR197075A1 (en)
BE (1) BE737417A (en)
CH (1) CH527155A (en)
CY (1) CY743A (en)
DE (1) DE1941625C3 (en)
DK (1) DK145778C (en)
ES (2) ES370540A1 (en)
FI (1) FI54099C (en)
GB (1) GB1264340A (en)
IE (1) IE33573B1 (en)
IL (1) IL32825A (en)
LU (1) LU59302A1 (en)
NL (2) NL155820B (en)
NO (2) NO137824C (en)
SE (2) SE363818B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1307284A (en) * 1970-03-16 1973-02-14 Boots Co Ltd 2-substituted phenyl propionic acids
JPS52168775U (en) * 1976-06-11 1977-12-21
JPS5327662U (en) * 1976-08-14 1978-03-09
DE2950608A1 (en) * 1978-12-29 1980-07-10 Chinoin Gyogyszer Es Vegyeszet METHOD FOR PRODUCING 2- (3-PHENOXY-PHENYL) -PROPIONIC ACID
CA1195691A (en) * 1980-01-28 1985-10-22 Ikuo Ueda Phenyl-alkanoic acid derivative and preparation thereof
NZ196163A (en) * 1980-02-07 1984-07-31 Richardson Merrell Inc Aromatic ethers and thioethers of glycols and hydroxythiols,pharmaceutical compositions
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
JPS6221294U (en) * 1985-07-23 1987-02-07
DE3610892A1 (en) * 1986-03-24 1987-10-08 Hubert Kurz Sectional sliding wall
JPS6412403A (en) * 1987-07-07 1989-01-17 Kuroi Electric Ind Co Light shielding panel
DE3816450A1 (en) * 1988-05-13 1989-11-16 Hubert Kurz Sectional sliding wall
DE3905518A1 (en) * 1989-02-23 1990-10-11 Bayer Ag SUBSTITUTED PHENOXYPHENYL PROPIONIC ACID DERIVATIVES
WO1993022269A1 (en) * 1992-05-01 1993-11-11 Pfizer Inc. Process for the preparation of 3(s)-methylheptanoic acid and intermediates therefor
SE0103325D0 (en) 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
AU2009234899A1 (en) * 2008-04-11 2009-10-15 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL274139A (en) *
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents

Also Published As

Publication number Publication date
BE737417A (en) 1970-02-13
NO137824B (en) 1978-01-23
NL6912504A (en) 1970-02-17
SE398639B (en) 1978-01-09
DE1941625B2 (en) 1981-05-07
IE33573B1 (en) 1974-08-21
NO137824C (en) 1978-05-03
SE363818B (en) 1974-02-04
NL7905644A (en) 1979-11-30
FI54099C (en) 1978-10-10
IE33573L (en) 1970-02-15
NO773495L (en) 1970-02-16
DE1941625A1 (en) 1970-11-19
IL32825A (en) 1973-03-30
CY743A (en) 1974-04-30
AR197075A1 (en) 1974-03-15
LU59302A1 (en) 1970-05-18
FI54099B (en) 1978-06-30
GB1264340A (en) 1972-02-23
ES370540A1 (en) 1971-07-01
ES390805A1 (en) 1974-03-16
NO139127C (en) 1979-01-10
CH527155A (en) 1972-08-31
NL155820B (en) 1978-02-15
IL32825A0 (en) 1969-11-12
NO139127B (en) 1978-10-02
JPS5145586B1 (en) 1976-12-04
JPS5144938B1 (en) 1976-12-01
DK145778C (en) 1983-08-22
DE1941625C3 (en) 1982-03-18

Similar Documents

Publication Publication Date Title
DK145778B (en) ANALOGY PROCEDURE FOR PREPARING 3-PHENOXYPHENYLALKANIC ACID DERIVATIVES
US3600437A (en) Substituted phenylalkanoic acids and derivatives thereof
JP2848964B2 (en) Retinoic acid X receptor ligand
US3558640A (en) Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3784697A (en) Pharmaceutical composition containing phenoxyalkane-carboxylic acids,salts and esters thereof
IE56204B1 (en) Leukotriene antagonists
EP0028063A1 (en) Phenol derivatives, processes for their preparation and pharmaceutical compositions containing them
EP0047536B1 (en) Substituted propylamines
US4031243A (en) 2-(4-Isobutyl phenyl)butyric acid, salts thereof, and pharmaceutical compositions containing the same
US3822310A (en) Substituted indenyl acetic acids
US4192809A (en) Certain 8-halodibenzofuran-3-alkanols
US4713486A (en) Novel compounds
IE45470B1 (en) Thiophene derivatives
US4219657A (en) Dibenzothiophenes
US3890377A (en) 3-Substituted phenylalkanohydroxamic acids
US4222944A (en) Halo-3-dibenzofuran alkanonitriles
US3853905A (en) Certain 5-(phenoxyphenalkyl) tetrazoles
US4001322A (en) 3-substituted phenylalkyl amines
US3972934A (en) 3-Substituted phenylalkyl amines
US2597445A (en) Nu-alkylamino-methyl-phenyl-propane and method of preparing same
US4304930A (en) Process for the preparation of 2-(3-phenoxy-phenyl)-propionic acid
NO150878B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-Naphthyl Acetic Acid Derivatives
US4334078A (en) Dibenzothiophenes
JPS6312064B2 (en)
US3361790A (en) Ether-linked acids and esters of triarylacrylamides